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THE NEED FOR CHANGE IN
MEDICAL EDUCATION

We have much to be modest about in medical
education, despite countless publications, conferences, and a great deal of hard work. Advances in medical science, outstripping advances
in medical education, are piling up masses of
detail that paralyze our present curricula. Medical school programs, long, unimaginative, and
overcrowded, tolerate and encourage mediocrity. Small wonder then that many bright college students find other branches of science or
other professions more attractive.
Most of us entered medicine with enormous
enthusiasm for learning how to care for sick
people, and all of us were dulled by two years
of pre-clinical work. Most of our students probably come to medical school for much the same
reason. Why then must we blunt their enthusiasm and kill their spirits with a year, or more
likely two years, of lectures and laboratories
that pay little more than lip service to clinical
correlations?
Since medical knowledge obviously will continue to grow, and since the capacity of our
crania will just as obviously not keep pace, we
must accept the fact that none of us is now,
nor will we ever train, the "complete physician."
We will do well to graduate a student who can
become a good house officer, viz., an adaptable
student who may enter his specialty training
with some idea of how to learn for himself,
how to read and think critically, and how to
obtain information from a patient. Only a paragon of students is able to survive a curriculum
clogged by vast quantities of unrelated facts,
and emerge untouched by mediocrity. These
factual details we can afford to leave in books,
which is where most faculty members have long
since left them anyway, after discovering that
they lead to mental constipation or worse. The
requirements for becoming a good house officer
are not great: the guidance of general principles,
a limited number of facts and skills, and much
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free time in which to think about them. Our
present medical schools do not provide such
programs.
How then can our present curricula be altered to provide programs marked by excellence? Perhaps this can best be accomplished by
profiting from the students' initial enthusiasm
for patient care; in other words, by giving them
the chance to live medicine and absorb it
through patient-centered teaching. From the day
they enter medical school, they could spend a
third of their time in the classroom, a third on
the wards, and a third in research, or, like warty
bliggens, for contemplation of "the moon and
wheeling constellations." Such teaching would
have to be done according to organ systems,
rather than by departments, and would require
active participation in all years by members of
all departments. But, who knows? Under such
a program, a student might discover that the
basic sciences do have some connection with patient diagnosis and care. He might retain his
curiosity and independence of thought, and
even achieve a sense of proportion.
A perusal of medical school catalogues shows
that most schools now use four years to obtain
33 months of actual instruction. Simultaneous
basic science-clinical teaching might make it
possible to obtain the same 33 months of instruction in a three-year period. Furthermore,
by encouraging independent study, such a teaching program undoubtedly would better prepare
a student for his specialty training. Our present
medical schools are no longer really medical
schools, anyway, but are pre-medical schools. It
is during the long years of postgraduate training that a man learns his clinical skills.
The key to tomorrow's medical practice lies,
not in the development of better clinical artisans,
but in the development of clinicians who can
interpret disease through application of the
basic sciences. A medical curriculum at a graduate student level, based on patient-centered
teaching with strong and continuous basic science correlation, could provide such clinicianscientists.
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An Approach to Medical Education:
The Medical College of Virginia
School of Medidne Curriculum*
EDWIN F. ROSINSKI

Medical College of Virginia, Richmond

Across the nation, medical schools are
re-evaluating their objectives and re-examining their teaching philosophies and
methods. Many have already adopted
new techniques and discarded old ones.
The Medical College of Virginia School
of Medicine began its own study of medical education in December, 1958, under
the former dean, William F. Maloney.
The result has been the elaboration of a
new curriculum, first put into effect this
past academic year, along with a number
of other changes in the educational program.-Ed.

* Development of the curriculum has
been supported in part by a grant from
the Old Dominion Foundation.

Until the middle 1950's, change was
conspicuously absent in the educational programs of medical schools.
The rapid growth of medical knowledge had no counterpart in medical
education. One reason for this stasis,
which lasted from the time of the
Flexner Report to the end of World
War II, probably was the concept of
medical education as a curriculum
(Flexner, 1910). The student took
prescribed courses; he spent a number
of required hours in the laboratory
doing experiments whose results had
been attested by previous generations
of medical students, and, at a designated time, he began several years of
clinical work. Adhering to this schedule and passing all the required examinations earned the student an M.D.
degree. Except in isolated medical
schools, there was little deviation from
this pattern.
Early in 1946, an article in the
Journal of Medical Education took to
task American medical education as it
existed then and had existed for 50
years. This article (Sanger and Hurd,
1946), co-authored by W. T. Sanger
who was then president of M.C.V., received relatively little attention then.
However, the criticisms and corrective
measures it contained foretold what
would happen five years later at
Western Reserve University School of
Medicine-the seat of the current
revolution in medical education. An
examination of this article is crucial to
an understanding of the present Medical College of Virginia curriculum
and of developments in medical education, in general. These were some of
the weaknesses in medical education
it named:
1) There is little provision for individual difference in medical educa-

tion. The medical school curriculum
is a lock step. Anyone who falls short
of this system is eliminated. This tends
to standardize a profession, allowing
no room for the student who is "different."
2) Too many short courses are
present. As new material is added to
the armamentarium of the physician,
the medical student receives it as a
"new course." The new material often
is not soundly organized in relation to
existing courses.
3) Unwarranted discrete units of
instruction are present. The division
between preclinical and clinical instruction is artificial; it cannot be defended on educational grounds.
4) The curriculum is too detailed.
The accumulation of centuries of
knowledge is added to continuously.
New knowledge is not integrated with
basic principles.
5) Teaching by departments leads
to autonomy; representatives of the
departments become increasingly unwilling to participate in integrated instruction, which is essential to effective
and permanent learning.
6) Course placement in the curriculum is arbitrary and a product of
tradition.
7) New concepts in sociology, psychology, etc., have not found their
place in the curriculum.
8) The medical curriculum has become too vocational and too professional.
Anyone familiar with the state of
medical education can see readily that
most developments during the past fifteen years have focused on correcting these criticisms.
There is an impressive number of
schools that have embarked on a critical evaluation and, ultimately, a
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change m their educational program.
Other than the Western Reserve curriculum, few schools have taken as
bold a step as the Medical College of
Virginia (Ham, 1959). Stanford University (Stowe, 1959), Northwestern
University (Cooper and Prior, 1965),
Johns Hopkins (1958), and Boston University (Soutter et al., 1959) implemented unique programs to meet their
particular needs. Harvard (Karnovsky, 1955), Duke (Woodhall, 1964),
and others have applied the same principles to their medical education programs that have guided their medical
science developments (Lee, 1962).
As in laboratory experiments, however, many efforts to revise medical
education have failed. The reasons for
these failures are probably comparable
to reasons for failure in the laboratory
-inadequately developed goals, poor
preparation, or an environment not
conducive to experimentation. In spite
of the failures, there probably is not a
medical school in the United States
that is not now seriously examining its
educational program, and seeking
efficient and effective ways to its educational goals.
Changes in Curriculum

After several years of planning by
a large number of faculty in a nearly
endless array of committees, a curriculum was designed. In this curriculum, the four years of medical school
are divided into three sections: MEDICINE 1 (Ml) approximates the freshman year of medical school and deals
with normal structure, function,
growth, and development ; MEDICINE 2 (M2) deals with abnormal
structure, function , growth, and development; and MEDICINE 3 (M3)
deals with the remainder of the clinical work. The four years of medical
education can best be described as the
study of human biology.
The subject matter committees are
organized by body systems as originally recommended. From an initial
consideration of the CELL, students
move along through RETICULOENDOTHELIAL SYSTEM, MUSCULOSKELETAL, etc., completing Ml with
the ENDOCRINE SYSTEM. The subject matter committees are chaired by
either a basic science or a clinical
4

teacher, who in turn is responsible to
the coordinator of Ml. Table 1 shows
the organization of Ml.
As seen in this table, several
unique features are present in this curriculum. MAN AND HIS ENVIRONMENT (M&E) encompasses the entire year. An objective of M&E is to
relate the content of the various subject matter committees to clinical material. In this phase of Ml, students
begin with a general consideration of
the role of the physician. After this,
they are concerned with the general
concept of illness and how this affects the patient. Psychological, social, cultural, and other factors are
considered. Accompanying this introductory phase, students are studying the material of the first subject
matter committee. It is possible then to
devote the remainder of M&E to clinical application of material of the subject matter committee.
Provision in the entire curriculum
has been made for FREE TIME AND
ELECTIVES. In the first year, during
a typical week, students have approximately ten hours of unscheduled time.
They are then allowed to pursue any
activity. However, the faculty is alert
that the students are free, and are instructed to channel that free time into
constructive academic pursuits. During the last half of the first year, and
all of the ensuing years, four hours of
the free time are spent in electives.
These electives can be didactic
courses, laboratory exercises, research
projects under the guidance of a faculty member, or work with a medical
practitioner on the faculty or in the
community. Students are expected to
enroll in electives in the second quarter. Although the present arrangement
of the curriculum is not based on departmental lines, electives are offered
by departments alone. With each year
of operation of the curriculum more
electives will be available. A the~is also
will be required prior to completion of
Ml.
Other Changes in Educational Program

Concomitant with the development
of a curriculum design, other changes
have occurred in the educational program.

1. Evaluation of Student Performance
There has been a complete reconsideration of ways to appraise student
progress. Previously, measurement of
factual knowledge was the focus of
nearly all examinations. Now, an evaluation committee, made up of subject
matter committee chairmen, considers
different techniques to measure all the
objectives of the medical school curriculum. A comprehensive examination is given at the end of MEDICINE
1. This examination attempts to measure, in a correlated and integrated
manner, material from all subject matter committees. It is the task of the
evaluation committee to ensure that
the examination does not merely measure isolated .pieces of information.
Members of this committee have access to consultant help on examination techniques.

2. Grades and Grading Procedures
With a comprehensive examination,
a new system of grading student performance has been introduced. Upon
completion of the work in each subject, a student can receive a grade of
either A, worth 3 quality credits; B,
worth 2 quality credits; C, worth 1
quality credit; I (Incomplete), worth
no quality credit; or F, with a minus
1 credit assigned. An I must be removed for promotion to M2. The
final comprehensive examination also
is graded by the same system. The
value of each subject matter committee's grade toward the final grade
is based on the per cent of time that
subject has been allotted in the total
academic year. Therefore, as CELL
BIOLOGY represents approximately
11. 7 % of the teaching time, and
RETICULOENDOTHELIAL represents 2.4 % of the time, the weight of
the total grade is based on this distribution. The following represents the
relative weights assigned to each subject matter, and to the comprehensive
examination.
Cell Biology
Reticuloendothelial
Musculoskeletal
Central Nervous System
Cardiovascular-Respiratory
Renal
Gastrointestinal

11.7 %
2.4%

9.3 %
5.7%
9.3 %
5.0 %
9.3 %

EDWIN F. ROSINSKI

Curriculum for Medicine I
SBIESTER DIVISION

Sl ' HJECT

WEEK

24FIRST TRl\IESTER

CELI. BIOLOGY

68-

RETICULOENDOTHELIAL

IOMUSCULOSKELETAL

12-

\!AN
AND HIS
ENVIRON·
MENT

FREE Tl\IE
ELECTIVES
RESEARCH

14CENTRAL
NERVOUS SYSTEM

16SECOND TRIMESTER

1820-

CARDIOVASCULAR
RESPIRATORY

22RENAL

24
26-

-

THIRD TRIMESTER

GASTROINTESTINAi.

2830ENDOCRINES

3234

REVIEW

AND

COMPREHENSIVE EXAM

36

Endocrines
Man & His Environment

9.3%
8.0 %
70 %

Comprehensive Examination 30 %
100 %
A final average of C is necessary for
promotion. Under this system it is
possible for a student who has had
difficulty in some subjects to bring up
his grade by doing well on the comprehensive examination.

3. Teaching Methods and Materials
Anticipating a curriculum revision,
a Teaching Materials Committee, in
operation for a number of years, began to explore the appropriateness of
some newer teaching techniques such
as programmed learning, closed circuit

television, filmed laboratory experiments, and self-study carrels. Because
a major factor in the success of this
curriculum depends on the students assuming responsibility for much of their
own learning, opportunities for self
learning must be provided through the
medical school. Many of these opportunities are available, but more
need to be instituted.
The choice of teaching methods employed in the curriculum remains with
the subject matter committee chairmen
and the faculty. Similarly, since the
chairmen function as an evaluation
committee, they also consider the
teaching methods to be used. In the
new curriculum, more is done in small
groups through conferences, seminars,
journal review sessions, and critiques.
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4. Studying the Effects of Curriculum Change
Objective evidence that the newly
instituted approach to curriculum approach better achieves the objectives
of medical schools has been lacking.
Since 1959, when it was anticipated
that a curriculum change might occur
at the Medical College of Virginia, a
committee began to gather comparative data on the old and new curriculums. For five years prior to the
curriculum revision, this committee
collected data on the student body,
faculty, and the effect of the curriculum on the school's objectives. This
study continues. In another four years,
the first objective of comparative evidence of a curriculum change can be
documented. Graduates of both curriculums will be included in the study
for several years after graduation. The
design of this study is beyond the
scope of this presentation.
For the Medical College of Virginia,
this curriculum is a major step in the
improvement of its educational program. The revision of courses of study
is only a part of the educational program, for the faculty defined curriculum as "the total educational experience of the medical student." In
addition, this school will be guided by
the statement in the last paragraph of
the schools' objectives: " ... the methods of attaining these objectives are
not static. The curriculum itself should
contain the machinery for frequent
critical review and re-evaluation by
the faculty and student body."
Summary

After a relatively long interval in
which the status quo was maintained,
in the early 1950's American medical
schools began to reappraise their educational programs. Many shortcomings of medical education which now
have been corrected were cited as
early as 1946.
The Medical College of Virginia began a detailed study of its educational
program. A curriculum has been designed and initiated, using the subject
matter committee approach. The curriculum provides opportunity for electives, research, and free time.
In conjunction with the revised curriculum, changes in grading pro6

cedures, examinations, and teaching
methods have been made. A study to
assess the effects of the change in curriculum also has been designed, and
the entire program is under constant
study to allow for additional changes
as they become necessary.
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What Motivates a
Medical Student?
"Traditionally, the term motivation bas also been used in psychology in another way; to account
not only for the degree of activity
a person manifests but also for the
fact that be moves in certain directions rather than others. This
definition seems more in keeping
with the connotation of the term
as it is used in the procedure for
selecting medical students. Here it
is usually phrased as 'motivation
toward a career in medicine' or
'motivating factors leading to the
choice of medicine.' Some like to
believe that the two kinds of motivation are intimately related, but
contemporary research makes this
appear unlikely. Strictly speaking,
the term motivation is not a felicitous one to use in discussing reasons for the choice in terms of
'personal values' or 'orientations.'
This does not imply that an appraisal of the applicant's value systems or orientations is unsuitable
in the selection process. It does imply, however, that the members of
an admissions committee who concern themselves with this problem
have identified certain values that
they prize more highly than others
in prospective physicians. It implies that without tangible evidence
as to what makes a good physician, they have decided that they
prefer to see in the candidate an
interest in helping people rather
than in making money, or an interest in medical research rather
than in attaining a position of
great social prestige or domination.
"A student questioned on these
points quickly recognizes that
values are involved. It is very possible that he is not aware of all
the determining factors that led
him to this choosing point in the
development of bis career, but
Christie (Christie, R. The Physician's Perception of His Role.
Paper read at meeting of the Eastern Psychological Association, Atlantic City, April, 1959) reports
that the typical applicant, when
asked why be chose to enter medicine, usually responds first in terms
of helping people. If be is then
asked what be would choose if be
were not accepted into medical
school, be does not pick a 'people'
field such as social science or
clergy, but rather a science field
like chemistry or biology. Several

hypotheses can be suggested to account for this sequence, but certainly one is that the applicant is
trying to match bis responses with
what he believes is expected of
him. The medical profession appears to value a service orientation
highly, and the candidate who does
not fit this pattern may find bis
chances for admission to apprenticeship lessened. At the same time,
analyses of contemporary American society show a predominant
achievement orientation (accumulation of money, of things, of
status), and if the student is a good
representative of the society in
which he lives this orientation
probably affects bis own value system. Should be then reflect this
society and lessen his chances for
admission, or should he respond in
the way which appears to be expected? Should the medical school
select chiefly those who are atypical of the society from which they
come (with the consequent problem of a markedly reduced pool
from which to select) or those who
are able to mouth the appropriate
responses without necessarily endorsing them? Or should the school
take the best possible candidates,
on the basis of other criteria, and
attempt to develop what they perceive to be an appropriate professional orientation during the subsequent training? This dilemma of
values the medical profession,
through the selection committees
of its professional schools, must
face realistically. Until it does, the
applicant who responds as be feels
he is expected to respond is probably showing good judgement. If
he were to do otherwise; the selection committee might reasonably
question his social sensitivity and
judgement, if not bis 'motivation
for medicine.' "
George E. Miller, ed.
Teaching and Learning in
Medical School. Cambridge,
Mass.: Harvard University
Press, 1961, pp. 12-13.
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Physiological Basis of the Radioisotope
Renogram
LOUIS D. HOMER*, HERMES KONTOSt, JOSEPH MAGEE, MALCOLM E.
TURNER, JAMES OATES, AND ALTON SHARPE, JR.

Departments of Medicine , and of Biophysics and Biometry, Medical College
of Virginia, Richmond

The renogram, a test of renal function
introduced in 1956 by Taplin et al.
(1956), is obtained by injecting some
substance tagged with radioactivity
which accumulates in a relatively selective manner in the kidney. Collimated
counters placed over the two kidneys
measure the accumulation of radioactivity, and its subsequent decrease.
When the counter is connected to
automatic recording devices, the curves
produced begin at the origin, rise rapidly
to a peak, and then fall in an approximately exponential manner. (fig. 3)
Blaufox, Orvis, and Owen (1963)
have done a compartment analysis of
Hippuran p 3i in dogs and have suggested that characteristics of the radioisotope renogram may be elucidated by
compartment analysis. The present
paper is based on a similar compartment
analysis. A different model, however, is
proposed to describe the renogram.
Estimates of the parameters are obtained
by the method of maximum likelihood
rather than by graphical means. In
addition, certain implications and possible application of the model, not discussed by Blaufox et al., are developed
here.
*Work supported in part by NIH
3676 and by NIH training grant 2G-693.
Submitted in partial fulfillment of the
requirements for an M.D. degree at the
Medical College of Virginia, Richmond,
Va.
t This work done in part during term
of a World Health Organization fellowship. Opinions expressed are not necessarily those of the World Health Organization.
B

c e b - extra-renal,
extra-vascular
cbe
comportment
ckb

h?!

Cuk

a

Fig. 1- 0rtho-iodohippuran is imagined to mix very rapidly in the blood,
and exchange with a non-vascular, nonrenal space. It is assumed that a constant
fraction of circulating hippuran is removed from the blood by the kidneys per
unit time .

a) Intravascular m1xmg takes place
very rapidly, compared to exchanges between other compartments.
b) Compartment u exchanges only
with k , k only with b and u, and
e only with b.
c) The volumes of compartments
b, k, and e are each constant.
We may write:

+ Cbe( Y e -

VbYb

- Ckb yb

v. Y .

Cbe( Yb - Y .),

Yb) ,

(1 )
(2)

where :

The compartment analysis to be done
is schematized in figure 1. Berman,
Weiss, and Shahn (1962) have published
a general treatment of compartment
analysis. Sapirstein et al. (1955) have
proposed the particular analysis used
here in deriving the blood curve for use
in renal physiology.

volume of compartment i,
the volume of compartment j
cleared per unit time with
transfer to compartment i. No
assumptions are made concerning mechanisms of clearance except that Cb e = Ceb ;
that is, there is no asymmetry
of mechanism between compartments e and b.
Y ; = concentration of the injected
substance in compartment i.
Yb and Y . are time derivatives of Yb and
Y., respectively. Equations (1) and (2)
are satisfied by

The Blood Curve

Yb = Bib exp ('Yit)

Assume the injected substance is
distributed principally into four compartments during the 20 minute duration
of the experiment. These compartments
are the blood, kidney, urine, and an
extravascular, extrarenal space, and are
designated by the subscripts b, k , u,
and e, respectively. It is also assumed
that:

where t is time, and Bib and B2b are
constants chosen to satisfy the initial
conditions. 'Yi and 'Y2 are the roots of a
quadratic equation,

v;

=

C ii

=

x 2 + (( Ckb / Vi)

+ B2b exp (-y2t)

(3)

+ (Cbe / Vi)

+ (Cbe / V.))x
+ (Cb.Ckb)/(V.Vi)

(4)
=

0
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The choice of a two-compartment system to describe the blood curve is based
on the suggestion of previous workers
(Saprrstein et al. , 1955) but is here
merely illustrative. More general systems might be used instead, and appropriate modifications made in the development which follows .
The Renogram

We consider the total kidney count
exclusive of contribution from other
tissues over one kidney, Yr to be given
by :

t

y, = Ckb'

Y b(s)ds

(5)

Arn and A 2R are constants determined
by Ckb', 'Y1 , 'Y 2, Bib, and B 2b. Since,
in fact , we may count over tissue and
blood as well as over kidney, the counting device will record,
YR

=

a1Yb

+ a 2.Ve + a 3y R + £X4Yu

(9)

where a; are constants determined by
the positioning of the detector, and the
proportion of each compartment will
appear in the counting field. YR , however, is still a linear combination of the
same exponential terms. So we may
rewrite (9) as
YR

=

Brn exp ('Y1t)

(10)

T

where s is a time variable of integration
c kb' is the unilateral clearance, assumed to be constant.
T=

0 ::::; t < a}
{ot for
- a for a ::::; t

a is the appearance time of orthoiodohippuran in the kidney.
The choice of limits of integration in
(5) means that we imagine y to be
simply accumulating within the kidney
until t - a. At that time, y begins leaving the kidney and appears in the urine.
If there is little or no longitudinal mixing
of urine within the tubules, the successively excreted quantities of y in the
urine will be just those quantities filtered
t - a minutes ago. Imagine an infinitely
long train of microscopic box cars, each
filled with an amount of y proportional
to Yb as it enters the kidney. It takes each
box car "a" minutes to leave the kidney.
Thus if we want to measure y at some
t ;::::: a, we sum up all the y which has
entered, and subtract all that came in
box cars which entered at some time,
t - a, and has now left the kidney.
That is,

(6)

·ds, t 2': a,

or
YR

=

c kb1

f

1

Ybds, t 2': a.

(7)

t-a

If we substitute (3) into (5), and integrate, we obtain for t 2': a,
YR

=

Arn exp ('Y1t)

+ A 2R exp ('Y 2t)

(8)

Brn and B 2R are constants .
The Urine Curve

Since the ortho-iodohippuran removed from the blood appears a short
time later in the urine, we write

where Cuk is the urine flow rate. Sodium
ortho-iodohippurate excretion (mg per
minute) at time t is simply equal to the
sodium ortho-iodohippurate cleared
by the kidney (mg per minute) at t - a.
The blood curve is evaluated at t - a
to predict the urine curve at t .
CukYu

=

Ckb' {B1b exp h 1(t - a)]

+ B 2b exp h 2(t

(12)

- a) ]},

For convenience we rewrite (12) as
(13)

Experimental Methods

Experiments were performed on dogs
anesthetized with intravenous sodium
pentobarbital (30 mgm per kg body
weight). Additional doses of anesthetic
were given during the experiment as
needed. Respiration was maintained
with a motor-driven pump following
intratracheal intubation. During the
preparatory period and throughout the
experiment, the animals received a
constant intravenous infusion of isotonic
saline, or a mixture of equal volumes
of isotonic saline and 5 % dextrose in
water.
Renograms were obtained with a pair

of matched scintillation counters (1 x 1
inch thallium-activated sodium iodide
crystals), connected to pulse-height
discriminators, ratemeters, and a dual
linear recorder. A time constant of 10
seconds, and a full-scale setting of 10,000
counts per minute, were employed. All
records were obtained with a paper
speed of 12 inches per hour. The tracings
were allowed to run for 15- 20 minutes.
The radioactive material used was
P 31-labeled sodium ortho-iodohippurate
(Hippuran ®) , obtained from Abbott
Laboratories. All renograms were obtained by injecting within 5 seconds 1.5
me of radioisotope per kg body weight
into the vein of a forelimb.
The experimental procedure was as
follows: The animal was placed in the
supine position and the peritoneal cavity
was entered through a midline incision .
The ureters were identified, divided at
their upper part and their proximal,
and cannulated with polyethylene tubing. To minimize dead space, the length
of ureteral catheters was kept short and
their tips were introduced into or very
near to the renal pelvis. Then the right
renal artery was dissected free and a
Crutchfield clamp was placed around it
without constricting the vessel. When
urine flow became constant, the probes
were placed immediately overlying the
exposed kidneys, and control renograms
were obtained. The position of the
probes remained the same throughout
the experiment.
Aortic blood was sampled through a
catheter placed into the lower aorta,
at 15 second intervals for the first 3
minutes following the injection of iodohippurate, and at 30 second intervals,
subsequently. All urine excreted during
the inscription of the renogram was
collected. Collection periods lasted 15
seconds for the first 3 minutes following
the administration of the radioisotope,
and 30 seconds, subsequently.
Blood and urine specimens were
counted in a scintillation-well counter,
for periods long enough to give standard
deviations not exceeding 1 %. Background and blank counts were subtracted from each count rate.
The urine count rate per second of
each specimen was divided by the duration of the period of collection in minutes to obtain the rate of excretion of
radioisotope per minute. The data from
9
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The data obtained for estimating the
blood curve (equation 6) consists of
Nb points (1, 2, · · · ,j, · · · , Nb) recorded
in counts per ml at successive time
points (ti, !2 , · · · , t;, · · · , tNb) .
Yb;

=

Bib exp ("/If;)

+ B 2b exp ('Y2f;) + Ebi'Pb(t;),

15

The likelihood function is proportional
to

(14)

=

Fig. 2- Counts/ sec in 1 ml of blood
at various times after injection of 1131
ortho-iodohippuran. Observed values
are shown as points . Estimated values
computed as Yb ; of Table 2 shown by
dotted line. Solid line obtained as Yb ;(Ho)
of table 2.

YR ;

6 , 666

=

+

z
~

4,444

(/)

I-

z

:::>
0
(.)

0
0

5

10

15

TIME (minutes)

Fig. 3-The renogram from which the
points shown in table 3 were obtained.
Circled points are the estimates labeled
f'R;(Ho) in table 3. The estimates labeled
f Ri actually fit somewhat better, but
this is not apparent graphically.
w

"'I
2

z
ii:

Brn exp ('YI!;)
B2R exp ('Y2l;)

+

(15)

in the urine

(16)

30

:::>

z

eu;cf>u(t;) is the error and Eu; has variance
cru2, but is otherwise like Eb; and eR;.
Equations (14), (15), (16) may be
summarized as follows:

Tl ME (minutes)

Fig. 4- 0bserved
and
estimated
(counts/sec) X 10-a excreted per minute
at various times following the injection
of p aI ortho-iodohippuran. Points are
taken from Yu; of table 4. The solid line
is estimated in the same manner as
Yu;( H o) of table 4.
10

+

Bu exp ('Yif;)

B 2; exp ('Y 2f;)
i
j

=

+

j=l

(2-Trcf>;;'cr ;')-I12

(17)
e;;cf> ;(t;);

b, R, u;

1, 2, ... , N ;;
cJ> ;(t;) =
=

Yi;

We will estimate the parameters by
the method of maximum likelihood (5).

(18)

Y ;; is the estimated value of Yat t ; using
the maximum likelihood estimates of
the parameters appearing in equation
(1 7). Taking the log of (18), and substituting into it e;; from (17), we obtain
L =

u

Ni

i=b

j=l

I: I: (- H log [27rcf>;;'cr;2])
- (Y ;; -

B I;

exp ['Y1t;]

(19)

- B,; exp l'Y2f;]) 2/ 2cf>;;2cr;2
In order to find those estimates of the
parameters which maximize L we take

o=

aL/ihI

=

aL;a'Y,
=

Yu = concentration of counts

=

i=b

eR;ci>R(t;),

eR;ci>R(t;) is as before the error; the eR;
are also taken to be normally and independently distributed with mean zero
and constant variance crR 2• Because of
the 10 second response time of the recorder, and the extremely rapid rise of
the renogram curve in its initial phase,
it was decided that this portion of the
curve was unsuitable for analysis, and
only the portion after the peak was used.
The urine data is in counts/ min per
minute of urine flow. Each datum has
the dimensions of (Cuk.Vu).

Y ;;

Ni

·exp (- [e;;cf>;(t;)]2/ 2cf>;;'cr;2 ) .

Tl ME (minutes)

Yb ; = counts/ ml at time t; , and
Eb;ci>b(t;) = "error;" the Eb; are taken
to be normally and independently
distributed with mean zero and
constant variance (for the blood
curve) crb2.
For the points on the descending
portion of the renogram curve we have

u

II II

aL ;aBli

=

aL;aB2 ;.

Papers on fitting equations of compartment analysis have been published
by Berman, Shahn, and Weiss (1962),
and Berman. A more general approach,
of which this problem is a special case,
has been made by Turner, Monroe, and
Homer (1963). Because equation (14)
is non-linear in 'YI and 'Y2 , these parameters must be estimated by an iterative
procedure. The procedure used in the
illustration presented here was as follows:
a) use trial values of</> ;;, ..Y1, . Y .
b) estimate B1; and B2i.
c) obtain new estimate of</>;; = Yi;
d) obtain new trial values of . Y I and

. Y 2.
e) Repeat the previous steps until
one finds a ..y, and . Y 2for which the
sum of the squared errors given by
N;

I:
j=l

= (e;;cf>;(t;)) 2 = SSE;

(20)

is lower than for other values of
'YI and 'Y2 in the neighborhood of
. Y1and ..Y2 .
The best values of ..YI and . Y 2are found
by this procedure for the blood, renogram, and urine, separately. When
estimating one curve at a time, no value
need be assigned to CT i 2• After the best
values of the parameters Bii, B 2i ,
'Yi i , 'Y2i have been obtained, SSE; may
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be computed, and an estimate of u ;2 is
given by
u ;2

=

SSE;/(N; - 4)

(21)

Using the combined data to find the
values of /'1 and '}' 2 which give the best
fit for all three sets of data at once requires a slightly different procedure.
First of all, as can be seen from equation
(19) , u ; 2 is required. An alternative is
to use estimates of u ;2 given by (21).
This alternative introduces a substantial
simplification into the numerical procedure at a cost of some information.
</> ii is kept constant instead of being reestimated after each iteration as is done
when analyzing the data separately.
The values chosen are those used in the
last iteration on each separate curve.
This restriction is necessary in order
to be able to compare SSE; obtained
using the combined estimates of '}'1 and
'Y2 . Finally a new criterion of fit must
be chosen. The best pair of 'Y 's for the
combined data was that pair which
minimized the weighted least squares
criterion S, given by
u

s = i=
L: ssE//er;',er;' = ssE;1(Ni b

4);

SSE; is the sum of the squared errors
for i set of data using the best separate
values of ..Y1 and ..Y2 , and SSE;' is the
sum of the squared errors for i set of
data using the best values of ..Y1 and ..Y 2
from the combined data.
A program was written for the RPC
4000 computer to perform the calculations described, and to print out the
estimates of the parameters, SSE ; and
R 2• R 2 may be interpreted as the percentage of variation in Y ; , which can be
accounted for by the hypothesis calculated by
R ;2 = 1 - SSE;

- & Y ij/</>ii'
(

Ni

J-1

I
) ' /

N .

{

i

;= 1

Y ;i'/c/>ii'

( ?:::Ni -:-:;l ) }
;= l

(22)

<f> ,1

Results

The data, estimates of parameters
and estimates of Y ;i , are given in tables
1 to 4 and figures 2 to 4.
An approximate F test may be devised
to test the hypothesis that /'1b = 'Y1k =
'Yiu , and at the same time, that 'Y2b =
'Y2k = 'Y2u . Using our previous notation,
we have

TABLE 1

Estimates of the parameters and statistics measuring goodness of fit . B1 , B2 ,
11 , and .Y2 have the same meaning as in the text . Estimates obtained from fitting
the -y's with pooled data and assuming /' 1b = /' 1k = /' 1u , and at the same time that
/'2b = /'2k = 1'2u , are in the second line of each pair.

I Sums of
fJ,

fJ,

.y,

72

Squares
due to
Error

31.14
58 .28

Coefficient
No. of Obof Deterservations
mination
---

---

Blood

26 .21
15.94

6.25
6.42

- .8178
- .5517

- .0893
- .0979

Renogram

58.45
72 .94

19 .60
19 .47

- .4915
- .5517

- .1001
- .0979

Urine

47 .50
55.27

3.60
7.22

- .4337
- .5517

- .0489
- .0979

F =

{[Ct

SSE/

15.32
18 .74

35
35

.994
.992

27
27

.982
.978

29
29

that these measurements are not related
in any simple fashion to either the
bilateral or unilateral renal clearance
of ortho-iodohippurate. According to
the model, the height of the maximum,
disregarding contribution from other
tissues, will be given by

/Cr.')

- (~b ssE.;er») J/ 4}

/Ct ssE.;er") / 19

3.462
4.267

.967
.939

=

9.5

with 4 and 79 degrees of freedom. We
may reject the hypothesis with greater
than 99.9 3 confidence (P < .001), in
favor of a hypothesis in which some or
all of the 'Y's are different. Attention
is called to the high values of R 2 • While
fitting the 'Y'S separately gives a significantly better fit, it is not much better
from the standpoint of the value of R 2•
The worst fit found has an R 2 of 0.94.
Examination of tables 1 to 3 shows that,
except for perhaps the first 5 points on
the blood curve, the estimates of Y ;
obtained with 'Y'S from pooled data are
very close to those obtained with the
separately estimated 'Y'S. Although the
differences are quite significant, they
are rather small. We can be relatively
sure that the 'Y's differ but the differences
may not be important.
Discussion

Clinical investigators have attempted
to characterize the renogram by measuring the height of the maximum, the
time of the maximum, and the "half
time" of the descending slope (Stewart
and Haynie, 1962). Our model predicts

from equations (14) and (15). This
maximum will depend on renal blood
flow since c kb ' should approximate
unilateral renal blood · flow. Yn(max)
will also depend on the appearance time
and bilateral renal blood flow. The relationship of the maximum and the appearance time to bilateral and unilateral
clearance is not a simple one. For example, Yn(max) might be unchanged in
spite of a decrease in unilateral clearance
if the appearance time were prolonged .
The time required for the renogram to
fall from its maximum to one-half the
maximum is often referred to as the
half-time of the renogram. Since the
proposed hypothesis describes the renogram as the sum of two exponential
functions , no simple interpretation of
the meaning of this half time is possible
in terms of the fundamental parameters.
Ortho-iodohippurate clearances are
considered rather direct measures of
renal blood flow. A scheme for analysing
11
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TABLE 2

TABLE 3

Observed and estimated counts/ secml in the blood at t ; minutes after injection of 11 31 ortho-iodohippuran.
Y b;, l\ ; , and Y b; (H o) are reported
in counts/ sec X 10- 1 for one ml of
blood . Y b; are the observed values.
Y b; = B ib exp (fi t ;) + B ,b exp (f, t ;)
where B ib, B ,b, fi, and f, are taken
from the top line of table 1. Y b;(H o)
is computed as Y b; except that Bib ,
B 2b , 1'1 , and ,,, are taken from the
second line of table 1.

Observed and estimated (counts/
min )/ 222.2 of renogram t; minutes after injection of 1131 ortho-iodohippuran . Y n; are obtained from the renogram in figure 3. Y n; = BIR exp
(1 1t ;) + B 2R exp (f2 t ;) where Bi n ,
B 2n , -91 , and f 2 are taken from line
3 of table 1. Yn;(H 0 ) is obtained using the estimates in line 4 of table I .

Y b;

t;
-

0 .5
0 .75
1.0
1.25
1.5
1.75
2.0
2.25
2.5
2.75
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10 .0
10 .5
11.0
11. 5
12 .0
12 .5
13 .0
13 .5
14 .0
14 .5
15 .0

12

Yb ;

Y b;(H o)

23.4
20 .0
17 .3
15 .0
13 .2
11.6
10 .3
9 .27
8 .39
7.65
7.03
6.07
5.37
4.84
4.44
4.11
3.85
3 .63
3.43
3.25
3.10
2.95
2.81
2.69
2.56
2.45
2.34
2.24
2.14
2.05
1.96
1.87
1. 79
1. 71
1.64

18 .2
16 .5
15 .0
13 .7
12 .5
11.48
10 .57
9.76
9.04
8. 40
7.83
6.87
6.09
5.46
4 .94
4.51
4.15
3.84
3. 57
3.34
3.13
2.94
2.77
2.62
2.48
2.34
2.22
2. 11
2.00
1.90
1.81
1.72
1.64
1.56
1.48

--

24 .3
22 .9
14 .3
13 .2
12 .9
11.2
11.4
10 .6
9 .5
7 .1
6.5
5 .2
5.0
5.1
4.7
4.2
3.9
3.9
4 .3
2.8
3.1
2.8
2.9
2.3
2.5
2.5
2.2
2.2
2.0
2.0
2.0
1.8
1.8
1. 7
1.9

tj

Yn;

-

Y n;

Y n ;(H o)

- -2.5
3.0
3.5
4 .0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10 .0
10 .5
11.0
11 .5
12 .0
12 .5
13 .0
13 .5
14 .0
14 .5
15 .0
15.5

32 .5
27.5
23 .8
22 .3
19 .2
17.0
14 .9
13 .4
12.4
11.4
10 .6
10 .2
9.7
9.0
8.4
7.3
6.9
6.6
6.3
6.2
6.0
5.8
4.9
4.7
4.3
4.5
4.4

32 .3
27 .9
24.2
21.3
18 .9
16 .9
15 .2
13.8
12 .6
11.6
10.7
10 .0
9.3
8.7
8.1
7.6
7.2
6.8
6.4
6.1
5.7
5.4
5.2
4.9
4.6
4.4
4.2

33 .6
28.4
24.4
21. I
18 .6
16 .6
14 .9
13 .5
12 .3
11.3
10 .5
9.8
9.1
8.6
8.1
7.6
7.2
6.8
6.4
6.1
5.8
5.5
5.2
5.0
4.7
4 .5
4.3

renograms which would permit estimates of these clearances to be made
might prove of great clinical value.
Using the model presented here, we are
able to suggest several different approaches to the analyses of the renogram
which should provide such information.
While the analyses suggested involve
procedures more complicated than
merely measuring the " half time," the
appearance time, or the height of the
maximum, much is to be gained in
simplicity of interpretation since the
analyses provide estimates of bilateral
and unilateral clearances, while no such
fundamental information may be easily
obtained from the simple measurements
referred to above. It is hoped that the
more precise and more easily interpreted
information thus obtained from the
renogram would be of sufficient clinical
importance to justify somewhat more
complicated analyses than have been
previously attempted.
Bilateral renal function may be
assessed with 'Y1 and 'Y2 . From the relationship of equation (4)
'Y1'Y 2

=

CkbCb e/ VeVb,

<J ('Y1'Y2) / <JCkb

=

Cbe/VeVb.

(23)

(24)

The left member of (24) is always positive so that a decrease in c kb should be
reflected in a decrease in 'Y1'Y 2. Perhaps
persons having decreased total renal
blood flow will have unusually low
values of 'Yi'Y 2 . Also from equation (4)
we have,
'Y1

+ 'Y2 =

-(Ckb / Vb

+ Cbe/ Ve + c b./ Vb) ,
a(,,1+ ,,,);ackb

=

-

1

-

Vb

(25)

(26)

As c kb decreases, 'YI + 'Y 2 increases
(becomes less negative). Thus, in general, persons with low renal blood flows
might be expected to have values of
'Y1 + 'Y 2 , less negative than persons
with higher renal blood flows .
The two parameters 'Yi and 'Y 2 could
be determined in " normal" patients,
and changes in 'Y1'Y 2 and 'Y1 + 'Y 2 might
be simply interpreted as changes in
clearance. If the blood curve were also
determined, it would be possible to
obtain numerical estimates of bilateral
renal blood flow, compartment volumes,
and compartment exchange rates, using
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TABLE 4

Observed and estimated (counts/
sec) X 10-3 excreted each minute in
the urine t ; minutes after the injection of 11 31 ortho-iodohippuran . Yuj
are the observations . Yu; = fJ ,. exp
(f ,1;) + B2u exp (.Y2 t ;) where B1u ,
B2u, 11 , and 12 are taken from line 5
of table 1. Y ;(H o) was calculated us
ing the estimates in the last line.
I;

Yu;

Y u;

Y u;(H o)

--- ---

2.0
2.25
2.5
2.75
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10 .0
10 .5
11 .0
11.5
12 .0
12 .5
13 .0
13 .5
14 .0
14 .5
15 .0

20 .8
16.8
21.5
19 .1
18 .0
14 .0
11.82
9.68
7.87
7.05
6.36
5 .24
5.07
3.51
3.72
3.63
3.33
3. 24
2.86
2. 79
2. 46
2.35
2.34
2.14
2.03
2.03
1.98
1.87
1.69

23 .2
21.1
19 .2
17.6
16 .0
13 .4
11. 3
9.63
8. 24
7 .12
6.20
5.45
4 .83
4.33
3.91
3.56
3.27
3.03
2.82
2.65
2.50
2.37
2.26
2.16
2.07
1.99
1.92
1.86
1.80

24 .3
21.8
19 .6
17 .6
15 .9
13 .1
11.0
9.26
7.93
6.87
6.03
5.35
4.80
4.35
3.97
3. 64
3.38
3. 14
2. 93
2. 75
2. 59
2. 44
2.30
2.18
2.06
1.96
1.86
1. 76
1.68

the equations of Sapirstein et al. (1955) .
With the additional information from
the renogram, unilateral renal blood
flows could also be computed.
Because of the contribution from
adjacent tissues to renogram counts, the
value of Brn and B2R in evaluating unilateral function is a more complicated
matter. Some investigators (Block,
Hine, and Burrows, 1960) have already
found YR(right) / YR(left) to be a useful
index of differences in function between
the two sides. This suggests that
B;R (right) / B;R (left) might also be useful.
As already said, the F test assures us

that the best fitting 'Yli's and -yds are
not identical, as the model requires.
There. are several possible explanations
for this. T he rejection is largely due to
difficulties with the early part of the
blood curve (fig. 2), an\:! thus might be
partly explained by difficulties in exact
timing, where a very few seconds may
make a large difference in the activity
of the blood sample in a period. Also
to be explored a re the possible effects
of changing blood flow (Ckb , Ckb' not
constant), and changing appearance
time. If the model fitted to available
data is indeed such a sensitive measure
of variations in renal blood flow or
urinary a ppearance time, it may prove
to be a valuable tool in studying these
variations, and in studying relationships
between these two parameters.
Summary an d Conclusions

A model elucidating the relationships
between blood radioactivity, the renogram curve, and urine radioactivity, as
a function of time, is derived. Estimation
procedures have been devised which use
the data from three curves at once to
estimate parameters common to the
three curves, and which also estimate
parameters unique to the individual
curves. A program has been written for
the RPC 4000 computer to perform the
estimation .
It was found that some model in which
six different exponential parameters
could be justified instead of the two
proposed by the model could provide a
significantly better fit of the data (P <
.001) , but that the fit under the hypothesis was still quite good. It is proposed that the model be retained for
further evaluation a nd study for the
following reasons:
1. It is based on soundly established
principles of physiology, and hence
provides a link between the renogram
curve and those principles.
2. The model fits the descending part
of the curve well.
3. On the basis of the model we are
able to suggest several improvements
in the analysis of renograms for clinical
evaluation of renal function .
4. T he model leads to reasonable
estimates of the time of the renogram
peak.
5. The model provides a framework

for further study of the renogram and
its relations to physiologic function in
general. More specifically, it may prove
to be a sensitive instrument in studying
rapid variations in urinary appearance
time and renal blood flow, and the
relations between blood flow and appearance time.
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On Science and Scientists
"I have been developing an ethic
for science which derives directly
from its own activity. It might have
seemed at the outset that this study
could lead only to a set of technical
rules: to elementary rules for using
test tubes, or sophisticated rules for
inductive reasoning. But the inquiry turns out quite otherwise.
There are, oddly, no technical rules
for success in science. There are no
rules even for using test tubes
which the brilliant experimenter
does not flout; and alas, there are
no rules at all for making successful general inductions. This is not
where the study of scientific practice leads us. Instead, the conditions
for the practice of science are found
to be of another and an unexpected
kind! Independence and originality,
dissent and freedom and tolerance:
such are the first needs of science;
and these are the values which, of
itself, it demands and forms."
"Science is not a mechanism but
a human progress, and not a set of
findings but the search for them.
Those who think that science is
ethically neutral confuse the findings of science, which are, with
the activity of science, which is not.
To the layman who is dominated
by the fallacy of the comic strips,
that science would all be done best
by machines, the distinction is puzzling. But human search and research is a learning by steps of
which none is final , and the mistakes of one generation are rungs
in the ladder, no less than their correction by the next. This is why
the values of science turn out to be
recognizably the human values: because scientists must be men, must
be fallible, and yet as men must be
willing and as a society must be organized to correct their errors. William Blake said that 'to be an Error
& to be Cast out is a part of God's
design.' It is certainly part of the
design of science."
J. Bronowski, Science and
Human Values with the
Abacus and the Rose. New
York and Evanston: Harper
& Row, 1965. pp. 62-64.

Radiotherapy m the Management of
Oral Cancer*
RALPH M. SCOTT

Department of Radiology, University of Louisville School of Medicine,
Louisville, Kentucky

Radiotherapy and surgery, used
singly or in combination, are the only
curative approaches to the treatment
of mouth cancer. Preoperative irradiation of advanced cancer is now being
evaluated, and shows much promise.
This may permit operation in previously inoperable cases, make less extensive operative procedures feasible
in others, and possibly decrease the incidence of cancer spread during surgery. However, while surgery often can
salvage radiation failures, the reverse is
seldom true.

Surgery and Radiotherapy in Oral
Cancer
Among surgeons acquainted with the
capabilities of good radiotherapy, and
radiotherapists familiar with good oral
surgery, one seldom finds major differences of opinion about the management of individual cases.
Each method has its advantages and
disadvantages. Any acceptable method
of treatment must have a good cure
rate, a low incidence of complications,
and should terminate in the best possible functional and cosmetic result. This
last criterion is the least important,
but makes radiotherapy of special interest in treating cancer of the mouth.
In instances where either method
might have equal chances of cure or
complication rates, a method that
would not interfere significantly with
function a nd appearance is preferable.
A normally functioning and normally
appearing mouth may not be essential
for life, but it is important to the enjoyment of life in our society.

* Presented at a seminar of the department of radiology, division of radiotherapy, Medical College of Virginia,
February 18, 1965.
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Cancer of the Lip

Cancer of the lip usually is easily
managed by radiotherapy. Its accessibility facilitates the evaluation of the
progress of treatment. Shielding adjacent areas from the x-ray beam is
easily done, and the results in properly
selected and treated cases should be
uniformly good. This does not mean
that surgery is never indicated. When
leukoplakia coexists and can be removed along with the cancer, surgery
generally is preferred. The irradiation
of lip cancer, be it new or recurrent,
near or at the site of previous intensive
irradiation, is to be avoided since overlapping these areas invites soft tissue
necrosis. The presence of regional
lymph node metastasis often will make
it desirable to excise these in continuity with the primary lesion. In extensive cases, invasion of the mandible
is regarded as a relative contraindication to irradiation since this predisposes
to failure and osteonecrosis.
Cancer of the Bucco! Mucosa
In early cancer of the buccal mucosa, surgery and irradiation give
about equal cure rates, but radiotherapy generally results in a better
functional and cosmetic result. Surgery is preferred for the more advanced fixed ulcerating tumors, particularly those with mandibular
involvement or regional node involvement; they are seldom cured by irradiation.

Cancer of the Tongue

The inaccessibility of carcinoma of
the base of the tongue dictates treatment by radiation therapy. The results in squamous cell carcinoma are
poor. Metastases to the regional nodes
are common, and often bilateral. Irradiation seldom will sterilize these.
Furthermore, these lesions generally
infiltrate deeply, and control of the
primary site is achieved rarely. Occasionally, lymphomas are encountered
in this region. Their prognosis is much
better because they are considerably
more radiosensitive.
Tumors of the lateral margin of the
tongue, and the occasional lesion of
the dorsum of the tongue, present a
more optimistic outlook for the radio~

therapist. A significant percentage of
these cases can be treated successfully
with little functional impairment.
Among the lesions to be avoided by
the radiotherapist are those with preexistent syphilitic glossitis, those with
marked sepsis and edema of the
tongue, those which have been previously irradiated, and the extensive lesions with mandibular involvement.
The anterior third of the tongue
can be treated by surgery or irradiation. Excision of this portion seldom
produces any significant functional
impairment, and surgery often is more
expedient.
The inability of ionizing radiation
conclusively to cope with metastases
to regional lymph nodes from squamous cell carcinoma of the oral cavity
has already been indicated. Since approximately 80% of patients with cancer of the tongue already have or will
develop node metastases (Ackerman
and de! Regato, 1954), a neck dissection, either prophylactic or for clinically evident disease, usually is a part
of the treatment.
Cancer of the Floor of the Mouth

Cancer of the floor of the mouth
responds well to radiotherapy if the
mandible is not involved and there is
no lymph node metastasis. Even in the
presence of node metastases, it often
is feasible to irradiate the primary site
and do a neck dissection, thus saving
the jaw. When cancer of the floor of
the mouth involves the mandible, with
or without nodes, curative therapy becomes a surgical problem. The same
general considerations apply to lesions
of both the upper and lower gingiva.
Malignancy of the Soft and Hard
Palates, Salivary Glands, and Tonsils

Lesions of the soft palate should
be managed by radiotherapy wherever
possible since extensive surgical procedures in this region generally result
in considerable disability in swallowing
and talking. Lesions of the hard palate
are more often handled surgically
since surgical defects in this region
usually are corrected easily with a
proper prosthesis. Adenocarcinomas
arising from the minor salivary glands
are common in this region and, in

general, are not as radiosensitive as
the more common squamous cell carcinomas.
Squamous cell carcinoma is the
commonest type of malignancy encountered in the tonsil, but lymphosarcoma is not unusual and reticulum
cell sarcoma and Hodgkin's disease occasionally are seen here. Irradiation as
the primary treatment is usually the
choice in each of these instances. The
majority of these patients show cervical lymphadenopathy at the time treatment is instituted. While the nodes are
included in the field of treatment, radical neck dissection may be necessary
following irradiation of the squamous
cell carcinoma. The lymphomas, being
much more radiosensitive, seldom will
need a neck node dissection.
Problems of Oral Hygiene

When radiotherapy is selected for
treating cancers of the oral cavity, the
preparation of the mouth for this treatment becomes one of the most important aspects of the therapy. It is
often necessary to include the salivary
glands in the treatment portals. This
causes a temporary suppression of
their activity that, depending upon the
dose, lasts for varying lengths of time.
With the high doses employed in the
treatment of squamous cell cancer, the
dryness usually persists for several
months and the normal flow of saliva
seldom is completely regained. A
permanent alteration in the chemical
and physical characteristics of the
saliva occurs. This presumably causes
the rapid acceleration of dental caries
which is common after irradiation. This
type of caries is somewhat peculiar in
that the decay occurs at the gingival
margin, and the most particular mouth
hygiene does not seem to prevent it.
In addition to dental caries, irradiated bone heals poorly and is subject to
bacterial invasion. Whenever extraction of teeth from irradiated bone becomes necessary, there is a high risk
of a chronic, intractable osteomyelitis
of this partially devitalized bone. All
radiotherapists do not agree on this
point, but most anticipate these possible complications and attempt to avoid
them by having extractions done prior
to irradiation.
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This type of tooth extraction should
not be looked upon as routine. Speed
is important so that treatment is not
delayed. The teeth should be removed
in as few sittings as possible. If this is
done, with all rough spicules of bone
rongeured away carefully, and the
gums carefully sutured, normal healing
usually results; it is seldom necessary
to delay the institution of therapy for
more than a few days. When the salivary glands are not to be treated, only
diseased teeth and those to be in the
beam need be extracted.
Selection of Radiotherapeutic Procedure

There are many methods of administering radiation therapy to the mouth,
and practically every technique has
some area of preferred use. Telecobalt
and megavoltage are being used in
most radiotherapy centers today; however, they have not, and will not, completely replace conventional x-irradiation, radon, and radium.
Conventional orthovoltage x-ray is
most useful in accessible lesions, such
as the lip or buccal mucosa, and in
the occasional small lesion that can
be treated with an intraoral cone. As
previously mentioned, shielding normal structures from this type of irradiation usually is done easily, while
shielding from supervoltage is quite
difficult.
Megavoltage irradiation and telecobalt are most useful in the less accessible lesions where it is necessary for
the radiation to penetrate bone in
order to reach the tumor. Because
photoelectric absorption is much less
with these modalities, the energy absorbed by the bone is considerably
less than it would be from a beam of
conventional x-ray; there also is less
shielding of the lesions by the bone.
A better tumor dose is achieved with
a lower given dose, and there also is a
significant decrease in skin effect as
the maximum ionization occurs subcutaneously.
Radon seeds, interstitial radium implants, and radium molds have the advantage of localizing the radiation to
the area treated. Little radiation
reaches other sites. This radiation is
of a quality comparable to megavoltage and telecobalt, and it has the same
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bone sparing effect. Radon seeds are
used primarily in small tumors which
are easily accessible for implantation,
such as the buccal mucosa, floor of the
mouth, soft palate, or tongue lesions.
Interstitial radium needles find their
place in the larger, deeper seated tumors of the tongue, floor of the mouth,
and buccal mucosa. They are used often with external irradiation. Radium
molds can be very useful in areas
where they can be made to fit properly,
such as the gingiva, hard palate, and
floor of the mouth. Some radiation
centers treat lip cancers almost routinely by sandwiching the lip between
two radium molds. In experienced
hands, this gives a very nice cosmetic
and functional result. The use of molds
by an inexperienced operator is not
recommended as they must be properly
applied and fitted to do the job well.
A more recent and little-explored
radiotherapeutic method of cancer
treatment is that of electron beam
therapy. The dose from an electron
beam is nearly constant to a depth
corresponding to the range of these
electrons in tissue, which in turn depends upon the accelerating voltage
of the machines. With the use of electron beam therapy, the deeper tissues
can be spared almost completely from
radiation effect, thus reducing complications, discomfort, and the difficulties
in maintaining nutrition during and
after treatment.

the treated areas are troublesome, but
should not be looked upon as complications. All possible attempts should
be made to minimize these reactions,
but usually they cannot be avoided
completely.
In a paper given to the American
Radium Society, Ash (1962) presented
5-year results on 1,624 patients treated
at the Ontario Cancer Institute, representing a 96% follow-up. The crude
5-year survival rates were given in detail by site and stage for cancer of the
tongue, buccal mucosa, gingiva, floor
of the mouth, and palate. The treatment policy primarily was radiotherapy, with cervical metastasis being
managed by radical neck dissections.
The overall 5-year results for all sites
and stages was 31.5 % . These results
are typical of what can be expected
today with good radiotherapy. Carcinoma of the lip and tonsil were not
included in these figures. The tonsil
should yield a 30 to 40% 5-year survival , and the lip about 80%.
Whatever definitive form of therapy
is used on any given case of oral cancer, one point seems worthy of emphasis. This disease involves many specialities in the field of medicine. For
this reason, a team approach to its
treatment is desirable. The dentist, the
pathologist, the surgeon, and the radiotherapist all have definite contributions
to make. Consultation among them
prior to the treatment generally will
be to the patient's advantage.

Complications of Radiation Therapy

The most serious complications of
radiation therapy in the treatment of
oral cancer are osteonecrosis and
osteomyelitis. The advent of megavoltage x-ray and telecobalt has helped
greatly to diminish the incidence of
these complications, but has not eliminated them. Effective treatment of cancer in any site requires radical treatment, and
radiotherapy is no
exception. Any method carrying a high
incidence of complications is not a
good one, but when complications
never occur, it usually is at the expense of undertreating.
The dryness of the mouth that occurs when the parotids are irradiated,
the aberrations in taste when the
tongue is treated, and the membranous
reactions of the mucous membranes in
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Laser in Clinical Ophthalmology: Possible
Applications, Limitations, and Hazards
WALTER J. GEERAETS

Department of Ophthalmology, Medical College of Virginia, Richmond

Since the development of the ruby
laser by Maiman in 1959, two major
questions have been raised with regard
to ophthalmology:
1. What is the feasibility for its
clinical use as a therapeutic device?
2. What are the hazards of accidental exposures among personnel
working with lasers in industry, research, and military installations;
how to counteract them?
After clinical light coagulation for
various ocular lesions had been included in the therapeutic armamentarium, the introduction of the laser
for similar purposes was obvious, and
has been accepted with enthusiasm by
various groups of clinical investigators. Since, at present, the ruby laser
is only used for ophthalmological purposes, the basic principles of its action
are briefly reviewed.
Fundamentals of Laser Action

When a photon is absorbed by an
atom, the energy of the photon is
converted to internal energy of the
atom. The atom is then raised to an
"excited" quantum state. Later it may
radiate this energy spontaneously,
emitting a photon and reverting to the
ground state or to some state in between.
In such an excited state the atom
can be stimulated to emit a photon, if
it is struck by another photon having
precisely the energy of the one that
would otherwise be emitted spontaneously. As a result, the incoming photon, or wave, is augmented by the one
given up by the excited atom. More
important, the wave, upon release,
falls precisely in phase with the wave
that triggered its release. There must

be an excess of excited atoms to enable stimulated emission to predominate over absorption.
In the ruby laser (aluminum oxide
poisoned with a few chromium atoms
-Maiman used .05% by wt of chromium), light in the green and yellow
bands is absorbed, while blue and red
are allowed to pass through. The absorbed light raises the chromium atoms
to the excited state from which two
steps are required to carry them back
to the ground state.
First, they give up some of their
energy to the crystal lattice and land
temporarily in a metastable state. If
not subjected to stimulation, their stay
at this level lasts a few msec while
they drop at random to the ground
state.
Photons emitted during this final
drop have a wavelength of 6,943 A
(at room temperature). In the laser,
however, the first few photons released stimulate the still excited chromium atoms to give· up photons and
return to the ground state much faster.
If a great number of atoms are excited, the ruby merely emits a burst
of its typical red fluorescence, spread
over the usual decay period for the
excited atoms. But above a critical
level, in which more than 50% of the
total atoms are brought in the excited
state, the atoms return to the ground
state at the very same moment. They
last approximately 200 to 500 µsec,
during which time an intense monochromatic light beam flashes from the
laser crystal. The beam is almost parallel if produced at threshold levels.
With greater energies increasing divergence occurs.
From the foregoing it becomes obvious that the characteristics of laser
radiation are different in several as17
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pects from the clinical light coagulator
used before. The most important differences are:
1) The spectral distribution of the
light source, and
2) The exposure time for production of chorioretinal "burns."
While the conventional Zeiss light
coagulator utilizes a xenon high pressure lamp with a spectral range
throughout the visible spectrum, the
ruby laser beam is monochromatic and
produces light at a wavelength of
6,943 A only. Moreover, the light coagulator allows the ophthalmologist to
control the exposure time by pressing
a button situated on the ophthalmoscope handle; thus the exposure time
is determined under direct vision of
the developing tissue response. On the
other hand, the exposure time with the
use of the laser is inherent within the
instrument, and is not controllable
during the exposure. Thus, while the
light coagulator exposures usually
range from about 0.1 sec to 1 sec, ruby
laser exposure times are in the neighborhood of 500 µ,sec .
These two factors-wavelength and
exposure time-however, are of fundamental importance with regard to
tissue reaction. During recent years
absorption characteristics of the human and the rabbit eye have been
studied, especially with respect to absorption distribution in the pigmented
layers of the ocular fundus. The data
were compared with reflection measurements from the ocular fundus, and
with light energies required to produce
ophthalmoscopic visible minimal lesions. Moreover, the influence of blood
flow on the development of ocular
thermal effect has been investigated.
More recently, a histological and histochemical comparison of ocular lesions produced with light coagulation
with those produced with a ruby laser
has been described. In later studies
exposure times for light coagulation
were 30 msec and 175 µ,sec, while
laser exposures were achieved with
200 µ,sec for "pulsed" and 30 µ,sec .
for "q-switched" laser action (Geeraets"
et al., 1960, 1962a and b, 1963, and
1965; Ham et al., 1963).
Clinical Considerations

Initial Promise and Present Limitations
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The Zeiss light coagulator has been
used for over a decade to treat such
ocular lesions as retinal detachment,
vascular lesions of the retina and
choroid, inflammatory chorioretinal
conditions, iris lesions, etc. As soon as
the laser was introduced, several of its
features seemed more advantageous
relative to this conventional light coagulator:
1) The price of the instrument was
expected to be considerably lower than
that of the Zeiss light coagulator.
2) The instrument promised to be
quite light so that it could easily be
carried to the patient's bedside, instead
of having to bring the patient to the
instrument.
3) The very short exposure times
wae regarded as beneficial, since with
these exposure times the patient would
not be able to move his eye, thus eliminating the need for retrobulbar anesthesia.
4) The dim red light of the laser
beam (A.
6,943 A) will not produce
photophobia, another reason for eliminating anesthesia.
5) The short-time, high-intensity exposures would allow much smaller lesions than those produced by light coagulation.
However, after several years of
clinical and laboratory experimentation, these anticipated advantages appear at present not as obvious or as
convincing as a number of investigators had initially expected. Moreover,
it is quite certain today that the laser
has not broadened clinical indications
nor has it opened new fields for therapeutic application of high intensity
light.
Several instruments utilizing the
pulsed ruby laser are now commercially available. With the desire to develop a therapeutic device having as
many safeguards as possible against
possible overexposures, the price and
weight of the instruments have both increased and are still rising; thus the expected advantages outlined above
under 1) and 2) seem not to be warranted. It is true, however, that the
short exposure time and the dim red
light do not necessitate retrobulbar
anesthesia of the patient's eye. This
minor advantage is contradicted by the
dangers of short-time exposures. When
the instrument is triggered, the degree
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and severity of the chorioretinal lesion
is decided upon. Even if the surgeon
has followed instructions and started
with low instrument settings-Le., low
energy output which does not cause
any lesions-and has slowly increased
the laser beam intensity, the exposures
are not without danger. The energy
output of the laser varies from shot to
shot in a random fashion unless special
precautions are taken. Moreover, the
energy control settings of the instruments have only a very small range
between therapeutically desirable intensities, and those which will produce
severe overexposures. With this narrow range, and the possible fluctuations from one exposure to another,
the usefulness of the instruments presently available is limited. Beside these
inherent limitations, the irregularities
in pigment distribution of the ocular
fundus add to the potential hazards
which might be encountered. Examination of a number of eyes treated
elsewhere with lasers, for various etiological reasons, revealed lesions which
were too severe and well above optimal therapeutic levels. Many of the
lesions showed centrally located retinal holes with small hemorrhages and
pigment clumps extending into the
vitreous.
There may be an advantage in producing chorioretinal coagulations with
very short exposure times when the
exposure has to be made in a region
where injury to the nerve fiber layer
may result in a large scotoma. Here,
the short exposure times allow for the
coagulation effect to be restricted to
the choroid and outer retinal layers,
thus sparing the inner layers of the
retina and the nerve fibers passing
over the lesion. This observation, made
in numerous experiments (Geeraets,
Burkhart, and Guerry, 1963), can be
explained by the absence of tissue
damage due to thermal conduction
during actual exposure time, if the exposure times are sufficiently short, i.e.,
in µ,sec . The lesions thus produced
must be very mild as heat conduction,
continuing from the site of coagulation
after the exposure has terminated,
might be sufficient to cause coagulation of all retinal layers.
The statement that smaller retinal
lesions can be produced with a laser is
true, but is of little clinical impor-
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tance. I have never observed a clinical
situation in which a lesion smaller
than that producible with the common
light coagulator was desired.
Use in Retinal Tumors

Retinal tumors have been mentioned as another indication for laser
treatment. Here, too, the same rules
can be applied that have been established for treatment of tumors with
light coagulation. One might even
speculate that the more extensive coagulation effect using common light
coagulation techniques may be more
destructive to tumor cells than the
laser beam. But the very restricted indications for coagulation treatment of
ocular neoplasm remains the same for
both methods.
Experimental data obtained on tumor transplants within the suprachoroidal space have shown some of the
restrictions one has to observe in such
attempts of treatment (Geeraets,
Ghosh, and Guerry, 1962; Chan et al.,
1963). In cases of retinal angiomata,
the red light of the ruby is reflected
to a great extent, thus unnecessarily
increasing the incident total light
energy applied to the ocular media
and other ocular structures.
Accidental Laser Exposures

With the very powerful devices developed for industrial, military, and
research use, accidental exposures of
the human retina have presented a
true hazard. Not only the direct exposure to the laser beam, but also laser
light from any reflecting surface may
result in permanent ocular injury.
Since light of the ruby laser (.\. =
6,943 A) is dim red, and light from
the neodymium laser (.\.
1,060 A) is
completely outside the visible spectrum, the potential hazard to the eye
is greatly enhanced as no immediate
discomfort is experienced by the victim. If the ocular lesion is mild and
located in the peripher)' of the retina,
the victim may not even be aware of
the accident. I have seen such lesions
on routine examination where there
was no doubt as to the etiology of the
lesion. If exposures occur to the fovea
or macular area, as in cases where the
patient is "fixing" the laser source
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along the axis of the laser beam or a
reflecting spot, the lesion may be of
serious consequence, even with mild
retinal lesions. And if both eyes are
involved, which most likely will happen if the patient is "fixing" on the
bright light, the developing macular
lesions may produce permanent visual
loss.
In case of high-intensity exposures,
for instance, as with the giant pulse
laser, central as well as peripheral
fundus lesions may lead to an explosion-like disruption of the retina and
choroid, with massive hemorrhages
into the vitreous, resulting in permanent loss of one or both eyes.
These accidental possibilities have
necessitated extensive precautions in
most installations and laboratories
where laser devices are used. Warning
signs have been placed in most locations during actual laser operation.
Laboratory facilities and equipment
have been painted with dark and dull
colors to reduce reflection. Special
goggles with hardened lenses and color
filters have been developed for eye
protection. But in spite of these precautions, accidental exposures are not
infrequent. Bright flashes of white
light produce photophobia and hence
constantly bring the danger of exposure to the persons working with these
light sources. With the dark red laser
beam or the invisible neodymium
beam this reminder is absent, possibly
explaining the observed negligence by
laboratory personnel involved. For
legal reasons it has been recommended
that any prospective employee to work
with, or in the vicinity of, laser devices be given a very thorough eye
examination by a qualified ophthalmologist to record all possible existing
fundus pathology or anomalies before
the person begins work. Routine follow-up examinations should be performed within reasonable periods to
insure that no accidental fundus exposures have occurred without the
person's knowledge. All reported possible exposures should get immediate
medical attention, since laser lesions
are more accurately determined the
sooner they are examined after exposure. After longer periods of time, scar
formation may not be differentiated
from other preexisting inflammatory
lesions.
19

LASER IN OPHTHALMIC PRACTICE
According to Tebrock, Young, and
Machle (1963), the principles of controlling environmental laser hazards
are:
1) Avoidance of the principal beam
and its reflections.
2) Proper education of personnel
involved.
3) General information given those
who might be casually exposed.
4) Use of warning devices to indicate laser is in operation.
5) Policing and clearing of area for
long range operation.
6) Use of proper antilaser eye
shields on any observer likely to be
exposed.
7) Use of count-downs with persons closing eyes or looking away
from pulsed, high-power beam.
8) Reporting of all persistent afterimages to medical department.
9) Funduscopic and slit-lamp examination of all people involved in
laser operations.
Conclusions

In spite of the limitations and potential hazards involved in ophthalmic
application of laser energy at its present status of development, further
clinical investigation is necessary. It
should be restricted to a few centers,
experienced in this type of work, and
aware of the fundamental physical and
biological mechanisms involved. In
reality, this practice is not always followed, thus increasing the potential
danger of the clinical use of lasers.
Although some of the available instruments are beautifully designed and
engineered, these attributes alone do
not justify their therapeutic use. In my
opinion, arrangements to make the
present existing laser coagulators commercially available to all clinical ophthalmologists are irresponsible, to say
the least. Some of the ophthalmologists are misled by erroneous advertisement and receive their instruction
from overzealous sales personnel lacking adequate knowledge of the physical principles of laser, or of the
biological, optical, and functional
characteristics of the eye.
Summary

The present status of laser appli20

cation in clinical ophthalmology is
discussed. The differences between
conventional light coagulator characteristics and those of presently available ruby lasers for clinical use are
compared. The limitations and hazards of laser therapy are stressed.
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What is a Modern Physician?*
SIR GEORGE W. PICKERING

Oxford University, Oxford, England

The first thing to remember is that
the patient is not just a pair of tonsils,
or perhaps, a skin, a prostate gland, or
a pregnant uterus. This is a person.
And it is essential that you should
treat the patient as a person, as an individual who has feelings just like you
and I have, who has a family background like you and I have, who has
personal, domestic, and business problems, as most of us have.
Now, the second thing I think we
have to take into account is our own
problems and our own ignorance. I
personally feel that if ever I know
anybody who knows more about the
subject than I do that I can call him
in, if it is necessary. One obviously
does not want to bring in a very eminent thoracic surgeon merely because
one's patient has an acute bronchitis.
But one would always like to feel that
if one gets into difficulties, one could.
I learned a great deal by being associated with two Sergeant-Surgeons
to Their Majesties. (The office of the
Sergeant-Surgeon is a very ancient
one, and it his function to accompany
the monarch into battle.) The first one
that I knew was Wilfred Trotter. He
became a fellow of the Royal Society
because of his contributions to psychology. He was the man who invented the herd-instinct. Wilfred Trotter was primarily a brain surgeon, but
he was an excellent general surgeon.
When he was asked to come and see a
very difficult patient, the patient always became like clay in Trotter's
hands. And I know how he did it. He
always listened to what the patient had
to say, and he made it plain that he
had listened, and not only that, that he
had ·understood. I think this is the first

* An informal talk to the medical
house staff at the Medical College of
Virginia, October 7, 1964.

function of any physician, whether he
happens to be what you call, I understand, a pill doctor, a cutting doctor,
or a talking doctor.
This second thing I learned from Sir
Thomas Dunhill, who was Trotter's
successor as Sergeant-Surgeon to the
King. Dunhill was an Australian, and
he started off as an assistant in a pharmacy in Melbourne, and he made
enough money to put himself through
medical school. He became an expert
in thyroid surgery and operated upon
the Princess Royal. He was such an
extremely safe surgeon that he then
was made Sergeant-Surgeon to the
Queen. Dunhill would not operate on
any of his patients unless I had seen
them first. (He ran the surgical service
and I ran the medical service together
during the war.) He always liked for
me to see his patients, in case he had
missed something. I remember that he
once told one of his patients, who was
getting a little impatient, "Mrs. Smith,
I'd like you to know that we like to
make our mistakes before we operate,
and not during the operation, or after."
Dunhill was prepared to take an enormous amount of trouble. Queen Mary
had some varicose veins. Dunhill did
not know what to do about varicose
veins, so he went to the Varicose Vein
Clinic at St. Bartholomew's. There he
watched the interns and residents injecting varicose veins. Then, next
week, he went to see what they looked
like, and he did some himself. Then,
the following week, he went to see
what his looked like. When he thought
they were all right, he went and did
Queen Mary's. So you see, I take the
view that a specialist ought to be a
physician,,basically, and that he should
put his specialty on top of being a physician, not instead of it. I frequently
find my colleagues in the ear, nose,
and throat department are quite unable to take off the patient's shirt. And

eye doctors are rather like that, too.
And I am afraid sometimes the psychiatrists are a little like this, too. I
am not sure that I think this is a good
idea. I think one wants to be a general
doctor first, and then a special doctor.
Could I pass onto the "machine"
side of medicine. I have spent a great
deal of my time working in laboratories. One of the things that one learns
when one works in laboratories is that
things can go wrong. And you sometimes find results which you cannot
repeat and you find that the standard
reagent has been made up wrong; you
find that something has happened so
that a record that you were getting is
not right. So I have come to regard the
laboratory as fallible. And so, as I like
to do things myself, and as I can take
my own history, and as I can make my
own physical examination, and as I
can test the patient's urine myself, I
tend to place as much or more reliance
on the history and the physical examination and the testing of the urine,
which are the things I do myself, as I
may on the results which come on
sheets of paper. The other thing that I
like doing a great deal is to add to my
own powers of visualization the powers
which are added when you make a
chap transparent in the x-ray department. I personally very much like to
go and see any patient I have screened
(fluoroscoped), so that I can actually
see with my own eyes what happens
when he becomes transparent, and
compare that with what I can see
when he is opaque. I have said enough
about what I think about the problems
of tomorrow's physicians, and I hope
somebody is going to disagree with me.
Dr. Pickering: What do the residents feel is their chief problem, Dr.
Thompson?
Dr. W. T. Thompson, Jr.: I think
that among the very real problems we
face here, as we talk with members of
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sils anymore. I think the general practhe department who are in training,
titioner is terrified of treating fractures
are how much training is necessary,
and what should the goals of training
because it is not true that the bones
are full of red and yellow marrow; they
be in terms of future practice. In other
are full of black ingratitude. Unfortuwords, what is the place of a general
practitioner versus one who is a supernately, they have a horrible habit of
producing large amounts in damages
specialist. We have an interesting decision in this school regarding the role
and therefore practitioners are a little
bit wary of them. They tend to always
of the general practitioner in medical
education and also in service to the
get sent to the orthopedic surgeon
public. There is no question that he is
now. So, with us, the general practian essential man in our medical comtioner has almost become a family
munity, and yet we have some diffiphysician. I think we increasingly feel
culty in knowing specifically what his
that the general practitioner should
role may be. We tend to think that it
have some training in surgery, and, of
varies from place to place. Some of the
course, ear, nose, and throats are very
important because they are so common
men here in training in the department
of medicine doubtless are going to be
in country practice, and skins are imgeneral practitioners. Others may be
portant because they are very common,
and pediatrics is important because
uncertain as to what a family internist
is and how much training he needs. I
there are lots of children, and psywonder if your staff thinks about their
chiatry should be important because
long-range goals in their formative
many of the problems have to do
years, and has similar problems about
with the mind. Yet the main training ought to be in internal medicine
how to make these decisions.
Dr. Pickering: I think we have. I
because it has to do with the whole lot,
think these are very general problems.
really. And it has to do with the paRegarding the first question, about the
tient as a whole. I think the important
length of time that one should take
thing about the general practitioner is
over training, I think this must vary a
that he is better at deciding if he needs
good deal. On the one hand, the adspecialist help, and, if so, what spevantage of this period of training is
cialist to call in, than the patient is
that you can work under a lot of peohimself. I think this is one of his major
ple who will tell you a great deal. Your
functions. Whether another general
responsibilities, in a way, are rather
practitioner should take part in his
limited to the kind of responsibilities
training, I do not have any very strong
that you get in a hospital. On the other
views. Our general practitioners feel
hand, there is your desire to be an inthey should. But, I think they inevitadependent person, so to speak, and the
bly take part in the training of the famfact that, in a way, your training is
ily physicians afterward, because he
going to be for the rest of your life. I
joins a group of them and they train
have learned, I think, really more since
each other.
I became a responsible person than I
Question: Would you tell us some
did when, so to speak, I was responsi- , differences between postgraduate eduble to someone else. So I think everycation in Great Britain and here?
body probably will have to decide to
Dr. Pickering: Yes. In Great Britain
choose between these two kinds of
it is less organized than it is here, and
considerations.
there the postgraduates have to pick
You know, there was a time when
up what they can. Here they have a
James MacKenzie, who was a general
great deal provided for them in the
practitioner and a physician and surway of seminars, conferences, and
geon to the Royal Victoria Hospital in
lectures. I think it is better organized
Barkley, made a lot of his important
in the United States than in Great
observations when he was operating on
Britain. We are trying to organize it
the abdomen of patients without any
and I hope we are going to get better.
anesthesia. Well, our general practiQuestion: Has socialized medicine
tioners do not operate on the abdomen
affected the number of people going
now. A lot of them used to make coninto specialization?
siderable income by taking out tonsils
Dr. Pickering: Yes. It has increased
and adenoids. They don't take out tonthem. At least, I would think it has
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increased them. By the way, why do
you call it "socialized medicine?" It is
very interesting. What we say is that
we have got a National Health Service,
but I always get asked a question of
this sort about "socialized medicine."
Really, the war started all this. You
know, I often tell people that the architect of the National Health Service is
a chap called Adolph Hitler, because
we developed the National Health
Service during the war. It was called
the Emergency Medical Service, and it
simply continued into the National
Health Service. What happened was
that, during the war, the big London
teaching hospitals and the big city hospitals were evacuated because of the
fear of bombing. Lots of country
places were upgraded, including the
old workhouse infirmaries, and they
got staffs of decent physicians and surgeons attached to them. It has been a
policy of the National Health Service
to see that a place like, say, Cornwallwhich you know is way down in the
southwest tip-that this is served by
a pediatrician, an obstetrician, a physician, and a surgeon, so that disease
was covered. Before they went there,
because the community was not rich
enough to support these people by
private practice, the local inhabitants
were rather badly served, except for
those who were rich enough to go to
London or one of the other big cities.
So my answer is that the National
Health Service has increased the number of specialists. The main complaint
with the Service, and this is very
justifiable, is that the general practitioners have a little more paper work in
that they have a lot of certificates to
sign. But they do not have to send out
bills. They are largely cut off from
hospital practice, and they have not
done as well financially as the consultants. I think the main problem in
our National Health Service now is to
make family practice sufficiently attractive to draw good people into it.
There is a working party at the moment
trying to achieve this.
Question: That's one of the big
problems we face, and how do you go
about making it attractive?
Dr. Pickering: I think there ought
to be a lot more ancillary help. I
would have thought it would be desirable for family practitioners to prac-
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tice from health centers in which they
had secretarial help, record keeping,
a nurse or two, a laboratory, some xray equipment, and that they would
arrange their time so that they worked
something like an 8-hour day, instead
of being on call the whole time.
Question: The problem here is not
the ancillary help, which most of the
practitioners can afford to hire. The
8-hour day is one of the problems.
But, I think another real problem is
that practitioners feel cut off in many
cases; they are so busy with their
practice that they don't have time to
keep up, and they get farther and
farther behind. That is why so many
of them come back for house-staff
training after some years of training.
Dr. Pickering: Well, we have the
same problem, only more so.
Question: We had a general practice
internship setup here. The usual procedure was to stay in it one year and
then go into some specialty. Another
thing about the local doctor-and he
may have got himself into it-is that
he has made himself a middle man. He
feels he is just shifting or directing patients to specialists, and feels quite
limited in scope and power.
Dr. Pickering: Our best ones are
very powerful with their patients. They
won't allow a surgeon to operate if
they do not think he is right. And I
think this is a good thing. We have
some extremely competent general
practitioners around about Oxford,
and they are terribly useful because
they save their patients from all kinds
of things that are not in their patients'
interest to have done.
Question: Our patients seem to get
their direction from the Readers' Digest. Actually, I believe our patients
are a little harder to manage. They
come up with ideas of their own. They
ask the bus driver what he would do,
read the Readers' Digest or Time, and
then come up with pretty firm ideas
about where they are going and who
they are going to see.
Dr. Pickering: One of the important
functions of my general practitioner is
to protect me from the orthopedic
surgeons, whose teeth water every
time they see me.
Question: Can your patients get to a
consultant without going through a
general practitioner?

Dr. Pickering: Difficult. Most consultants will not accept a patient unless
he is sent by a general practitioner. It
can be done, but it is not easy.
Question: I wonder how often your
general practitioner's hand is guided
or forced when a patient comes to
them with some idea of who he wants
to see. This to me seems to leave no
defensive position at all.
Dr. Pickering: He has got to do that.
If the patient says, "I want to see
someone," he has to send him there.
Question: One of the objections to
the National Health Service is that
there are so many unnecessary calls on
the physicians. What do you think can
be done?
Dr. Pickering: I don't think anything can be done. There always have
been a lot of unnecessary calls. There
always have been patients who abuse
their doctors. I remember vividly
meeting a Canadian doctor who told
me that his father was a general practitioner in the country in Ontario. When
he was about 12, his father got a night
call in the winter. Because there was a
lot of snow on the ground, the old
doctor took his son with him. They
had to dig themselves out of one or
two snowdrifts. When they got to the
farmhouse, the baby was born, and
the grandmother upbraided the doctor
for being late. As they were going
away, the boy said to his father, "Dad,
why did you stand for that sort of
thing?" And the doctor said, "Well,
son, you know, this is just one of those
things. This is the sixth child I have
delivered for them, and they haven't
yet paid me for the first one."
Question: Does the general practitioner, by being denied the privilege of
seeing the hospital patients, have his
perspective seriously narrowed? Can
he stay "modern" without hospital experience?
Dr. Pickering: Well, I think that depends how the local hospital caters to
him, what advantage he takes of it,
and how he reads. But I see your point.
On the other hand, it has protected the
patient a great deal because we do not
now have incompetent surgeons trying
to remove breasts and that sort of
thing.
Question: Has there been any
change in the quantity or quality of

young men who aspire to be doctors in
Great Britain?
Dr. Pickering: It is generally supposed that the quality has fallen off,
but the quantity is terrific. We still
only take about one applicant in six or
seven, but I am constantly being pestered by schoolmasters and parents
who cannot get their boys into medical
schools. I think the falling off in the
quality of the students reading medicine is a general phenomenon. I
know it is happening at several schools
in this country. I think it is because
there are many attractive alternatives,
such as space research, agriculture,
physics, and even business.
Question: Is there any truth in the
claim that this country is draining
England's medical brains?
Dr. Pickering: Oh yes. But you've
been doing this now for about 300
years.
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Central Nervous Control of Blood Pressure
in Man; Preliminary Report*
D. W. RICHARDSON, A. J. HONOUR, AND A. C. GOODMAN

Medical College of Virginia, Richmond

Clinicians have long recognized the
importance of the mind in the moment-to-moment regulation of blood
pressure in their hypertensive patients.
Ayman and Goldshine (1940) long ago
demonstrated that blood pressure measured by a physician in a hospital clinic
was always higher than the pressure
recorded by the same patient or by
a member of his family in his home.
Pickering's group (Richardson et al.,
1964), using an automatic blood pressure recorder, has recently shown that
elevation in blood pressure ranging
from 10 to 50 mm Hg occurred when
a physician entered the patient's room
merely to say a word of greeting. Figure 1 illustrates the dramatic rise in
the pressure of a hypertensive subject during examination by an unfamiliar neurologist who concluded,
within the patient's hearing, that brain
damage was present.
To study further the relation between cerebral activity and blood pressure, we have recorded electroencephalograms and intra-arterial blood
pressure in normal people during
natural sleep.

continuously through a soft plastic
catheter inserted into a brachia! or
radial artery. Cerebral electrical waves
and eye movements were recorded
with a Grass electroencephalograph
from electrodes pasted on the scalp
and beside the eyes. Rate and depth
of breathing were recorded with pneumographs placed around chest and
abdomen. The subjects slept on their
backs in a bed in a dark, quiet room.
Recording equipment and observers
were in an adjoining room. No sedatives were givt:n.
The depth of sleep was assessed
240
230
220

The subjects of these experiments
were twenty-two healthy volunteers,
five women and 17 men, aged 19 to
51 years, two hypertensive patients
recently recovered from heart failure,
and one totally-nephrectomized man
awaiting renal transplantation. Blood
pressure and heart rate were recorded

* Presented at the Thirty-sixth Annual McGuire Lecture Series at the
Medical College of Virginia, October 8,
1964. Supported in part by grants from
the Virginia Heart Association and the
Richmond Area Heart Association.
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from the electroencephalogram by the
scheme of Oswald (1962). Dreaming
was recognized by the occurrence of
rapid conjugate eye movements during light (stage B) sleep, as first pointed
out by Dement and Kleitman (1957),
who observed that subjects awakened
just after a burst of rapid eye movements described dreams vividly. On
the other hand, if they were allowed to
sleep for 5 to 10 minutes after the eye
movements stopped, and were then
awakened, their recall of dreams was
diminished or lacking. These eye
movements signal the presence of
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Fig. I- Arterial pressure and pulse rate recorded indirectly at 5-minute intervals
for 24 hours in a young, hypertensive man. At 2:40 p.m. he was awakened from a nap
by a consultant neurologist. At about 1 a.m. he fell asleep. Reproduced by permission
of the editors of Clin . Sci. (Richardson et al., 1964) . Variation in arterial pressure
throughout the day and night.
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dreaming but provide no information
about the content of the dream.
In three subjects, the changes in
blood pressure which follow the type
of paroxysmal cerebral electric activity called K complexes (fig. 3) were
observed before and during blockade
of ,8-adrenergic receptors with 5 mg of
propranolol given intravenously without waking the subject (Courtesy of
Dr. Alex Sahagian-Edwards of Ayerst
Laboratories, 685 3rd Ave., N .Y . 17,
N.Y.). Blockade of ,8-adrenergic receptors prevents the increase in cardiac output and heart rate induced by
stimulation of sympathetic nerves,
without preventing the peripheral arterial constriction which sympathetic
neural discharge produces. The use of
propranolol thus can yield information about the mechanism by which
cerebral activity produces a rise in
blood pressure. The effectiveness of
,8 blockade was tested in each subject by intravenous infusion of 10 µ.g
of epinephrine per min. This produced marked elevation of blood pressure and slowing of the heart when
given after propranolol, instead of the
usual response of tachycardia without
change in mean blood pressure.
Results

1. Effect of Sleep
In four healthy subjects, systolic
pressure fell more than 60 mm Hg between the highest waking pressure and
the lowest sleeping pressure; in ten,
systolic pressure fell more than 50 mm
Hg. The average fall in systolic pressure for nineteen normal subjects was
49 mm Hg. Diastolic pressure fell less
than systolic, with an average change
from waking to sleeping of 29 mm
Hg. About 40 % of the total decrease
in pressure occurred while the patient
was resting prior to onset of sleep; the
remaining 60 % occurred after sleep
began. Prompt rise in pressure occurred as soon as the subjects awoke
in the morning, and during brief periods of wakefulness during the night.
Subjects whose waking pressure was
highest experienced the largest decreases in pressure during sleep. No
clear correlation was observed between
depth of sleep, judged by the electroencephalographic criteria, and level of
blood pressure.
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Fig. 2- Intra-arterial pressure (upper tracing) recorded continuously during the
end of sleep in a healthy young man. The periods marked REM indicate rapid eye
movements associated with dreaming. During the periods marked "a" there was brief
arousal. Each vertical line represents 5 seconds. The entire graph represents 5.Yz minutes . See text.

2. Dreams
Figure 2 shows a typical example of
the variable changes in blood pressure that occurred during periods of
rapid eye movements which indicate
dreams. The bars marked REM indicate the bursts of rapid eye movements. The periods marked " a" indicate brief wakefulness following each
dream. The first dream did not alter
blood pressure. During the 2nd and
3rd dream periods, blood pressure fell
slightly. In other subjects, a rise of
pressure as much as 45/ 30 mm Hg
that reached levels of 180/100 mm
Hg, occurred during the periods of
rapid eye movement. Each subject
showed considerable variability in the
response of arterial tension to dreams,
perhaps related to varying content of
the dreams.

3. K Complexes
During sleep of moderate depth,
there occur paroxysmal bursts of cerebral electrical activity called K complexes, which are characterized by one
or more large (50 to 200 µ.v), slow
(0.5 to 1 cycle per sec) waves on
which are super-imposed regular,
higher frequency (about 14 cycle per
sec) waves called sleep spindles. The
large, slow waves are recorded all over
the head ; the spindles are maximal in
the frontal regions. The anatomic site
of origin of K complexes, and their
functional significance, are unknown.
K complexes frequently follow within
a few msec a noise or a light flash,
but may occur without obvious external stimuli. Many of these K complexes are followed by a rise in blood

pressure, as shown in figure 3. Heart
rate speeds slightly as the pressure
rises following a K complex, and slows
below the resting rate at the height
of the rise. The rise in arterial pressure begins two or three heart beats
after the onset of the K, and lasts
10 to 20 seconds. In six healthy subjects whose records have been completely analyzed, K complexes were
associated with an average rise in systolic pressure of 18 mm Hg, with
maximal rises of 35 mm Hg in two
subjects.
4. Blockade

of

,8-Adrenergic

Re-

ceptors
In three healthy subjects, effective
blockade of ,8-adrenergic receptors,
as indicated by reversal of the usual
effects of intravenously administered
epinephrine, did not modify the
pressor response to K complexes. Figure 4 shows the rise in pressure occurring with a K complex after the injection of propranolol, the ,8-blocking
drug, into the same subject shown in
figure 3 prior to injection of propranolol.
Discussion

1. Circulatory Effects of Sleep
Sleep reduces blood pressure in
normal and in hypertensive people
(Richardson et al., 1964). The neuroanatomic basis for this circulatory
change is unknown in man, but ablation experiments in animals indicate
that connections between the reticular
formation in the midbrain and the
cerebral cortex are necessary for wake25
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fulness (Oswald, 1962). A current hypothesis suggests that activation of the
cerebral cortex by ascending impulses
from the mesencephalic, reticular, activating system produces wakefulness,
and that impulses from the same area
result in sympathetic discharge to the
heart and blood vessels, either indirectly by activation of higher brain
centers, or more directly by descending fibers to the medullary circulatory
centers.
Clinical application of sleep as therapy for high blood pressure has been
used by Russian workers who have
induced prolonged sleep pharmacologically in the management of hypertension. The long-term efficacy of such
therapy is not well evaluated.

2. Dreams
Snyder et al. (1964), using indirect
(cuff sphygmomanometric) and discontinuous measurement of blood
pressure have concluded that the
blood pressure of twelve subjects in
30 nights of sleep averaged slightly
higher during the rapid-eye-movement periods, which indicate dreaming, than at other times. This is a
conclusion not borne out by our continuous blood pressure records. The
same authors also found that blood
pressure and heart rate vary more
during dream periods, an observation
which our data support. The dramatic
rise in pressure occasionally seen with
dreaming has obvious clinical import
regarding nocturnal angina and paroxysmal nocturnal dyspnea.

W.T.O.

BEFORE PROPRANOLOL

·~ION

Fig . 3- Respiration, intra-arterial pressure and frontal and occipital electroencephalograms from a healthy man during sleep of moderate depth. Each vertical
line represents 1 second. See text.

W.tO. AFTER

PROPRANOLOL

3. K Complexes
The short interval between the onset of K complexes and the subsequent rise in blood pressure (two or
three heart beats) suggests strongly
that neural pathways are used exclusively to transmit the message from
brain to circulation; it is unlikely that
adrenal medullary (or other) hormones
could be released into the circulation
and reach the effector area in so brief
a period. Observation of similar hypertensive responses to K complexes
in a totally nephrectomized patient
demonstrates that the kidneys are unnecessary for this kind of elevation in
blood pressure.
Since propranolol, which blocks the
26
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Fig. 4-Response of blood pressure to K complex during 13-adrenergic blockade.
See text.
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cardiac excitatory effects of sympathetic nerve discharge, did not modify
the hypertensive response to K complexes, we presume that the K complexes stimulate sympathetic vasoconstrictor nerves to peripheral arterioles,
causing an increase in peripheral vascular resistance, and consequent elevation in blood pressure. The hypertension associated with K complexes
clearly demonstrates the importance
in man of cerebral activity in momentto-moment control of blood pressure.
The immediate relation between cerebral activity and elevation of blood
pressure increases interest in the role
of the brain in chronic (essential) hypertension, and as a contributing factor
in the abnormal physiology leading to
paroxysmal nocturnal dyspnea and
nocturnal angina.
Summary

1. Electrical activity of the brain,
eye movements, arterial pressure, heart
rate, and respiratory rate and depth
have been recorded continuously during a night of sleep not induced by
drugs in 22 healthy subjects, two hypertensive patients, and one anephric
man who was awaiting renal transplantation.
2. Sleep was associated with reduction in arterial pressure averaging 50
mm Hg systolic and 30 mm Hg diastolic.
3. Dreams, although occasionally
associated with marked elevation of
blood pressure, were usually accompanied by no change or a slight fall
in pressure.
4. The dramatic paroxysmal electroencepl;ialographic alterations termed
K complexes, occurring spontaneously
or after a noise in sleep of moderate
depth, were followed within two or
three heart beats by abrupt elevation
in arterial pressure, as much as 35 mm
Hg, lasting 10 to 20 seconds. Blockade with propranolol of ,B-adrenergic
receptors, which mediate cardio-excitatory effects of sympathetic nerve
discharge, did not modify the hypertension following K complexes.
5. Cerebral activity, transmitted by
sympathetic peripheral vasoconstrictor
pathways, is an important regulator
of blood pressure during sleep in man.
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Treatment of Hypertension*
EDWARD D. FREIS

Department of Medicine, Georgetown University School of Medicine ,
Washington, D. C.

Our ideas about the management of
hypertension have changed considerably in recent years. There is now general agreement that all patients with
accelerated hypertension, as manifested by high diastolic pressure and
Group III and IV funduscopic
changes, should have their blood pressure reduced with antihypertensive
agents. Differences of opinion still
exist, however, in respect to the treatment of the less rapidly advancing
types of hypertension. It is apparent
that the life history of untreated essential hypertension varies widely
from those patients whose lives are
cut short in a matter of a few years,
to those who survive to old age. The
problem is further complicated because antihypertensive treatment is
neither simple, innocuous, or inexpensive.
If we are to approach a solution to
this problem we need to know the
answers to two questions. The first is:
Does antihypertensive treatment prevent the organic complications associated with hypertension? and the
second, How can we recognize and
differentiate the patient who will develop serious complications from the
patient who will live out a normal span
of life?
Is Therapy of Hypertension Necessary?

Let us consider first the question of
blood pressure reduction in preventing organic complications. The evidence is very good that any form of
treatment which lowers blood pressure
has a beneficial effect on hypertensive
congestive heart failure. Cardiac failure has fallen from a major cause of
death to a minor cause in adequately

* Presented at the Thirty-sixth Annual
McGuire Lecture Series at the Medical
College of Virginia, October 8, 1964.
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treated hypertensive patients. In addition, since antihypertensive treatment
is effective in reversing the accelerated
phase of hypertension, it follows that
the transition to the accelerated phase
should be prevented in adequately
treated patients. There also is evidence
that the incidence of cerebral hemorrhage has been reduced. Thus, it appears that antihypertensive therapy is
useful in preventing congestive heart
failure, accelerated hypertension, and
cerebral hemorrhage.
There are as yet no reliable data
to indicate whether antihypertensive
treatment prevents atherosclerotic
complications such as myocardial infarction and cerebral thrombosis. It is
apparent that hypertension accelerates
and aggravates the atherosclerotic
process. Hypertension in some way
predisposes the arterial walls to the
deposition of atherosclerotic plaques.
Atherosclerosis is commonly found in
the pulmonary artery, for example, in
long-standing pulmonary hypertension,
and in the aorta in the region of high
pressure above a coarctation. Once
formed , however, it seems highly unlikely that atherosclerotic plaques
could be influenced by antihypertensive treatment. In addition, we know
that chronic elevation of pressure
leads to structural changes in the arterial walls, including fragmentation
of elastic tissue. It is possible that
these irreversible structural changes
provide a favorable environment for
the development of atherosclerosis
even after the blood pressure has been
reduced. These considerations suggest
that blood pressure must be lowered
in the early stages of hypertension if
antihypertensive treatment is to favorably influence the future course of
atherosclerotic complications.
We have similar evidence that hypertension leads to the structural

changes in the renal arterioles that we
call nephrosclerosis. The rapidity of
development, and the severity of the
nephrosclerotic process, appears to depend on both a persistently high diastolic pressure and a susceptible individual. In the presence of renovascular
hypertension, where a stenosis of one
renal artery is present, producing a
pressure drop across the narrowed
segment, nephrosclerosis develops in
the opposite kidney whose arterioles
are exposed to the high systemic pressure. In the kidney with the pressure
drop, whose arterioles are exposed to
a more normal pressure, nephrosclerosis is minimal or nonexistent. If
nephrosclerosis is to be prevented, this
again suggests that elevated blood
pressure must be lowered at a relatively early stage in the disease.
If there is a relationship between
elevation of blood pressure and atherosclerosis, as well as nephrosclerosis,
then it is reasonable to assume that the
extent of these pathological changes
will depend on both the height and
the duration of the blood pressure. If
the blood pressure is high for only
brief periods of time, and is normal
at all other times, we would not expect
to find vascular pathology. However,
if the pressure is high all of the time,
both day and night, and if this persistently high pressure lasts for many
months or years, then vascular pathology would be expected.
Variability of Blood Pressure Readings

Blood pressure represents a variable
manifestation. It can be strongly influenced by emotion, particularly by
fear and apprehension. There are some
individuals who from childhood manifest transient elevations of blood pressure, associated with apprehension,
who never develop a persistent eleva-

EDWARD D. FREIS

tion of blood pressure throughout a
normal life span. These individuals
may, ii;i middle and older age, exhibit
pressures of 230/ 130 or even higher
during a visit to a doctor's office or a
clinic, and yet at home their blood
pressure will be -normal. Such hyperresponsiveness may develop in middle
age, particularly in females, or in old
age in both sexes, as was shown by
Pickering almost 30 years ago. These
individuals may show very little organic progression.
Other hypertensive patients exhibit
elevation of blood pressure throughout
the day, whether they are at home or
hospitalized. These patients will almost
all exhibit organic changes, - and the
rate of progression varies in general
with the height of the diastolic blood
pressure.

Predicting the Prognosis of Hypertension and Need for Therapy

Thus, in evaluating hypertensive patients for treatment, we should consider not only the height of the blood
pressure but, more important, its persistence or duration. When we measure blood pressure only in the office or
clinic we should realize that we are
being presented with a mixture of
populations, some of which have severe pressure elevations most of the
time, some with considerably less hypertension than they exhibit in the
office most of the time, and some which
are not hypertensive at all but hyperreact to situations associated with apprehension.
Another way of estimating prognosis is to determine whether organic
changes are already present. We
should utilize the history, the funduscopic examination, the electrocardiogram, chest x-ray, and renal function
tests to estimate the degree of such
damage. Unfortunately, these changes
do not become apparent by ordinary
clinical tests until structural damage is
already well advanced. As pointed out
previously, if antihypertensive treatment can -be expected to produce a
beneficial effect in preventing nephrosclerosis and accelerated atherosclerosis, it should be given in an early
stage of the disease.
It seems evident, therefore, that

physicians should obtain · a more acc~rate estimate of the average blood
pressure than has been customary in
the past. If the office blood pressure is
not a reliable guide, then we should
determine what the blood pressure is
under more representative circumstances. The most representative blood
pressure that is practicably obtainable
is that recorded in the home, not by
the physician but by the patient himself, or better yet, · by a member of his
family. The office nurse can easily and
quickly teach such individuals how to
record blood pressure, and a few manometers can be kept on hand for twoweek loans. The pressure should be
recorded morning and evening for two
weeks in the home and the record
brought to the office on the next
scheduled visit. Frequently, the blood
pressure readings drop immediately or
ov~r a period of days to normotensive
levels. However, the finding of a persistent diastolic elevation above 90
mm of H g is an important criterion for
instituting antihypertensive treatment.
The higher the elevation, the more intensive the treatment will be. Of
course, it is important to make certain
that the blood pressure is being taken
accurately by having the individual
record the pressure in the physician's
presence at the time of the office visit.
Other useful prognostic indices, besides the estimate of the average blood
pressure and the survey for organic
damage, are the age, sex, and race of
the patient, and the rate of progression. These factors are well known
and require no emphasis.
Antihypertensive Drugs

Saluretic Agents (Thiazides); Reserpine
and Hydralazine
In the patient with persistently elevated diastolic blood pressure, but
with little or no signs of organic damage, treatment can begin with an oral
saluretic agent. This generally is not
sufficient by itself to reduce the diastolic pressure to normal. If it is not,
0.5 mg of reserpine twice daily for two
weeks, followed by a maintenance
dose of 0.25 mg once daily can be
added; or else hydralazine (Apresoline) may be added in a dose of 25 mg
two to three times daily. If the latter

is not effective, the dose can be increased gradually to 50 mg three times
daily.
Saluretic agents plus reserpine frequently provide an effective combination therapy in uncomplicated hypertension. The regimen also is convenient
because long-acting diuretics can be
combined with 0.25 mg of reserpine, to
be taken only once daily.
The principal toxic effect of reserpine is mental depression. Generally,
the more intelligent the patient, the
greater the danger of reserpine-induced depression. Unfortunately, other
alkaloids of Rauwolfia are not very
effective as antihypertensive agents
and, therefore, cannot be substituted.
It is important when prescribing reserpine to tell the patient that if he
should begin to feel unaccountably
depressed or to develop sleep disturbances, such as early morning awakening, he should immediately discontinue
the drug. In addition, one should
strive for the lowest possible maintenance dose, which lies between 0.1
mg and 0.25 mg daily in different patients.
The serious toxicity associated with
hydralazine is definitely dose dependent. The chief toxic reaction consists
of a syndrome resembling disseminated lupus which rarely, if ever, occurs when the total daily dose is maintained at 150 mg or less per day. The
acute side effects of hydralazine can
be avoided by a few simple maneuvers.
The first is to add hydralazine to the
regimen of a patient already being
treated with a diuretic or reserpine or
both. The latter two drugs, and particularly reserpine, tend to combat or
neutralize the acute hydralazine side
effects which are headache, palpitation, and tachycardia. The second maneuver is to institute the drug in low
and widely spaced doses, increasing
gradually. For example, hydralazine
can be started in a dose of 25 mg once
daily, increasing in two or three days
to twice daily, and after a similar interval to three times daily. It is surprising how frequently a small dose of
25 mg two or three times daily is effective in uncomplicated hypertension
when it is added to the diuretics with
reserpine, or to reserpine alone. The
trial of hydralazine, however, should
not be abandoned until the dose has
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been increased to 50 mg three times
daily.

Drugs in combination
The results of the large scale doubleblind V.A. Cooperative Study on Antihypertensive Agents clearly showed
the additive effects of these three drugs
in producing a reduction of blood
pressure. The combinations of reserpine and thiazides, or of hydralazinereserpine, or hydralazine-thiazide were
clearly more effective in reducing
blood pressure than any of these
agents used alone. The combination of
all three agents was most effective, reducing the average diastolic blood
pressure to below 90 mm in the patients that had been classified as having hypertension of mild and moderate
severity.
In patients whose blood pressures
are not controlled with any of these
combinations of diuretic-reserpine and
hydralazine, it is advisable first of all
to make certain that you are not being
misled by high office recordings. Patients whose blood pressures are well
controlled at home may completely
overcome the antihypertensive effects
of the drugs in the office or clinic.
Here again a record of home blood
pressures, taken over a two week period, will go far to clarify the situation.
Since the saluretic agents are used so
widely in the treatment of hypertension, it is important to consider their
adverse reactions. The most common
disturbance produced by thiazides is
a reduction in serum potassium levels.
This usually causes no difficulty unless
the patient is receiving digitalis alkaloids, in which case arrhythmias frequently are induced, due to the increased activity of digitalis in the
presence of a reduction in extracellular potassium concentration. Although
it is customary to advise ingestion of
excess potassium in this circumstance,
this cannot be depended upon to raise
the serum potassium level.
Another frequent side effect of thiazide administration is hyperuricemia
due to inhibition of renal tubular secretion of uric acid. In azotemic patients, this frequently precipitates attacks of gout.. It seldom does in
non-azotemic patients. It is advisable
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to control the blood pressure without
thiazides in patients who develop gout.
However, at times the situation demands thiazide treatment. In such a
case probenecid is given to combat the
hyperuricemia and colchicine is administered when necessary to control
symptoms.
Patients with severe renal damage
and acidosis often are unable to conserve salt. If they are placed on salt
restricted diets, and at the same time
are given thiazides, nitrogen retention
may be intensified. The administration of sodium bicarbonate or sodium
lactate to such patients sometimes results in diuresis with a fall in BUN
and in the degree of acidosis.
Diabetes mellitus is occasionally precipitated by thiazides. The incidence
of this complication is low and it is
difficult always to distinguish between
spontaneous diabetes and the drug
induced variety. Finally, thiazides may
induce hypersensitivity reactions with
skin rash and, on rare occasions, thrombocytopenic purpura.

Adrenergic Blocking Agents
If the response to a combination of
diuretic plus low doses of reserpine
and hydralazine truly does not control
the blood pressure, the physician has
the choice of using diuretics plus
adrenergic blocking agents, such as
methyldopa (Aldomet), guanethidine
(Ismelin), or pargyline (Eutonyl).
Orthostatic hypotension poses the
main problem in administering the adrenergic blocking agents. The physician
should be prepared to deal with this
side effect if he is to effectively treat
patients with severe hypertension. The
important points in managing patients
undergoing treatment with the blocking drugs are these:
1) Use saluretic agents in conjunction with blocking drugs whenever
possible. The former tend to smooth
out the large diurnal fluctuations of
blood pressure induced by the blocking agents, and to maintain a more
constant antihypertensive response
from one day to the next. Saluretic
agents also increase the responsiveness
of the blocking agents, permitting
lower doses of the latter.

2) Tell the patient at the time treatment is begun that the drug lowers
the blood pressure in the erect position, that it may reduce it to such a
point that he feels faint, but that the
dose can be adjusted so that this
symptom will not be troublesome.
3) Tell the patient that, if he does
develop weakness or faintness, he is to
discontinue all antihypertensive medications for that day and remain in
bed until the faintness disappears. If
the faintness has disappeared by the
next day, he is to begin again at a
slightly lower dose of the blocking
agent, specifically a decrease of 10 to
20% . If the dose is drastically reduced, the antihypertensive effect will
disappear. The aim, therefore, is to
find the maximum tolerable dose, and
this is frequently just below the one
which produces symptoms of orthostatic hypotension.
4) Tell the patient to be cautious
about drinking alcohol, as the latter
in conjunction with blocking drugs
may induce symptomatic hypotension.
Strenuous exercise also may precipitate orthostatic hypotension.
5) Doses are titrated up to the
effective level. The initial dose is small,
but it is increased gradually until an
antihypertensive effect or symptoms of
orthostatic hypotension occur.
6) Reassure the patient that if orthostatic faintness or syncope occurs, it
is not as serious as it seems; that it is
equivalent to an ordinary faint, and
that it can be avoided by proper regulation of dosage.
7) If the patient complains of orthostatic faintness, particularly in the
morning, and if the office blood pressures are still elevated without a fall
on standing, it may be either that the
orthostatic effect disappears in the
afternoon or evening, or else that the
office recordings are abnormally elevated due to apprehension. If possible,
the patient should visit the office in
the morning when pressures are usually the lowest. Best of all is to have
twice daily recordings taken in the
home by a member of the family or
the patient himself. Home blood pressure recordings are an invaluable adjunct in the treatment of severe hypertensive patients whose blood pressure
levels are difficult to control.
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Relative Merits of Methyldopa, Guanethidine, and Pargyline
Methyldopa is well tolerated because it produces less severe orthostatic hypotension and does not usually interfere with sexual function. It
also depresses renal function less than
guanethidine in patients with renal
failure. On the other hand, it is effective in controlling blood pressure in
only about half ot the patients with
severe hypertension. Three to four
doses per day are required as compared to only one dose per day of the
other blocking agents; it occasionally
produces fever and hepatitis, and it is
more expensive than the other drugs.
Methyldopa is begun in a dose of 250
mg three times daily, increasing as
necessary to a level of 750 mg four
times daily. Elevations beyond this
level generally produce little additional
antihypertensive effect. The most fre~uent side effect is drowsiness, which
1s usually transient, tending to disappear after a stable dose level has
been maintained for several weeks.
. Guanethidine or Ismelin is begun
~n a dose of 10 mg once daily, and is
mcreased every week by 10 mg until
orthostatic hypotension or a reduction
in supine pressure appears. In hospitalized patients or in those with severe hypertension, the doses can be
raised more rapidly. The maximum
dose is about 200 mg daily, although
most patients will exhibit an antihypertensive effect in the range of 25 to 75
mg when thiazides are given adjunctively.
Guanethidine probably lowers blood
~ressure .in a greater percentage of patients with severe hypertension than
does any other drug. Dosage also is
co~venient since the total daily reqm~eme~t can be taken once daily in
coniunction with a long-acting saluretic
agent. No hypersensitivity reactions
or serious organ toxicity have been observed. Because it is a potent blocking
agent, it is capable of inducing profound orthostatic hypotension. Once
the dose is regulated, however, patients
generally are not disturbed by this side
effect. Diarrhea may be troublesome
and usually calls for a slight reduction
in dose. Atropine-like compounds, as
well as paregoric, also can be used to
combat this side reaction. While under

the influence of adrenergic blockade
impotence occurs because orgasm i~
associated with ejaculation into the
urinary bladder.
Another blocking agent in current
use is pargyline or Eutonyl. Effective
doses vary widely from as little as 10
mg to as much as 100 mg per day. If
the latter dose is ineffective, larger
amounts generally will not be effective.
Pargyline is a monamine oxidase inhibitor and "psychic energizer." It
does produce increased alertness and
drive, sometimes to the point of inducing insomnia. Severe orthostatic hypotension can occur even in low doses.
The onset of this latter effect may be
delayed for several weeks or longer.
For this reason, the doses should be
gradually elevated with increases at
widely spaced intervals several weeks
apart.
Patients taking monamine oxidase
inhibitors may develop severe and even
fatal hypertensive responses following
the ingestion of processed cheese. This
unusual side effect is thought to be
due to tyramine which is present in
cheese.
It can be seen from this brief review that all antihypertensive agents
are potentially toxic. The decision to
treat a given patient, therefore, should
not be undertaken lightly. To the risk
of toxicity must be added the inconvenience and expense involved in lifelong treatment. An assessment of the
average blood pressure and the extent
of organic damage already present will
help in separating those patients who
require no treatment, and in determining in the remainder how intensive the
therapeutic program need be. The
deat~ rates from hypertension, hypertensive heart disease, and cerebral
hemorrhage appear to have been strikingly reduced since the advent of antihypertensive drug treatment. Therefore, this note of caution is not meant
to discourage the application of antihypertensive agents, but rather to advocate care and discrimination in their
use.
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Clinical Hemodynamics and
Pharmacodynamics of Toxemia*
FRANK A. FINNERTY, JR.

Georgetown University Medical Center, Washington, D.C.

For many years toxemia has served
as a wastebasket for a variety of disease states characterized by an elevated arterial pressure, edema, and
albuminuria. Whereas this triad is consistent with the diagnosis of toxemia,
it is not diagnostic. Besides toxemia,
these abnormalities may be found in
pregnant patients with hypertensive
vascular disease, pyelonephritis, glomerulonephritis, or any combination
of these (fig. 1). Data derived from
studies performed on patients with
such a variety of disease entities have
obviously been confusing. It makes a
lot of difference, for example, whether
the subjects studied had chronic pyelonephritis or acute vasospastic toxemia.
During the past 13 years, our group
has attempted to cut the pie of elevated arterial pressure, albuminuria,
and edema into separate and distinct
diagnostic pieces. Ophthalmoscopic
examination and urinalysis have been
of great help in this regard (Finnerty,
1954, 1956 and 1965; Finnerty et al. ,
1960).
Diagnosis

The finding of normal fundi and albuminuria suggested pyelonephritis.
Clumps of cells in the urine and a positive colony count documented the diagnosis.
Figure 3 gives the diagnostic breakdown in 4,273 patients followed in our
toxemia clinic during the past 3 years.
It is interesting to note the frequency
of pyelonephritis and hypertensive vascular disease, and the relative rarity
of true toxemia. The recent biopsy
studies of Altchek (1961) would seem
to substantiate the finding that most
patients originally thought to have toxemia actually have some other disease.
The specific biopsy picture for toxemia
has for the first time significantly clarified this wastebasket of syndromes. It
would seem that toxemia is another
type of glomerulonephritis. Figure 4
shows the similarity between toxemia
and glomerulonephritis. Both diseases
are characterized by a greater rise in
the diastolic than the systolic pressure,
which causes a narrow pulse pressure.
The edema is particularly in the periorbital areas, hands and feet. Ophthalmoscopic examination reveals thread-

Toxemia was diagnosed when the
ophthalmoscopic examination revealed
spasm of the retinal arteries with no
retinopathy, and urinalysis revealed
only albuminuria (fig. 2). Hypertensive
vascular disease existed when the retinal arteries were either normal or
thickened and tortuous with AV nicking. When both signs of chronic vascular disease and acute vasospasm
were observed with or without albuminuria, toxemia was then superimposed on hypertensive vascular disease.

* Presented at the Thirty-sixth Annual
McGuire Lecture Series at the Medical
College of Virginia, October 8, 1964.
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Fig.1.-Elevated blood pressure, albuminuria and edema are seen in toxemia
but also in several other conditions.
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DIFFERENTIAL DIAGNOSIS

TOXEMIA~

like arteries and generalized wetness of
the retina. Both diseases are characterized by albuminuria.
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THE DIAGNOSIS IN 4 273 PATIENTS
1961 - 1963
PURE TOXEMIA ••••••••••••••••••••.••...••.•.•.•..• 167
TOXEMIA+ HYPERTENSIVE VASCULAR DISEASE ....... 42
TOXEMIA+ PYELONEPHRITIS ...................... . . 67
PYELONEPHRITIS •••••••.•.•....•...•......••....... 704
PYELONEPHRITIS +HYPERTENSIVE VASC . DISEASE ... 287
HYPERTENSIVE VASCULAR DISEASE .. . ... . ........... 804
GLOMERULONEPHR ITI S •••••.•.•.•..••.•.•. • .......•. 84
NON-RELATED MEDICAL DISEASE ..................... 214
(ANEMIA, HEART DISEASE, ETC.)
EDEMA WITHOUT DISEASE. ....... . ....... . .......... 387
ASYMPTOMATIC BACTERURIA ••...••.• • •.•. • . • .•.••.. 469
NO DISEASE •••.••••••..••••...... • .....••......•... 944
QUESTIONABLE DIAGNOSIS ••••.••.•••. • ...•••....... 104
TOT AL
T,273

Fig. 3-Diagnostic features in patients attending the toxemia clinic
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All the signs and symptoms of toxemia may be adequately explained by
abnormal sodium retention and generalized vasoconstriction (fig. 5). The
relationship between the two is unknown, but clinical observation attests
that sodium retention usually precedes
generalized vasoconstriction, and that
prompt therapy of sodium retention
usually prevents generalized vasoconstriction. The studies of Eisenberg
(1959) in patients with acute nephritis,
and Finnerty (1962) in patients with
toxemia, show that there is an increase
in plasma volume without an increase
in circulating red cell mass. Following
diuretic therapy the plasma volume returns to normal. This pattern of blood
volume expansion, therefore, contrasts
sharply with that in patients with congestive heart failure in whom there is
a commensurate increase in red cell
mass and plasma volume. These data
suggest that an abnormality of salt and
water metabolism is solely responsible
for the hypervolemia of acute nephritis and toxemia.
A decrease in the amount of blood
to a particular area due to increased
vasoconstriction explains the remainder of the abnormality. An increase in
cerebral vasoconstriction causes cerebral ischemia, leading to coma and
convulsions. It is interesting in this regard to emphasize that it is cerebral
ischemia, and not a rise in arterial
pressure, that is the important abnormality in inducing coma and convulsions. The exact same symptoms may
be caused by postural hypotension or
an attack of Stokes-Adams syncope.
Evidence of both sodium retention
and vasoconstriction, the two pathophysiologic abnormalities, can be visualized ophthalmoscopically. A wet,
glistening appearance of the entire
SIMILARITY
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retina (retinal sheen) and a decrease in
the caliber of the retinal arteries characterize toxemia. The observation that
the generalized sheen of toxemia is
promptly decreased following diuretic
therapy strongly suggests that it represents retinal edema.
Increased constriction of the peripheral vessels seems to account for
the elevated arterial pressure. The increase in arterial pressure in toxemia
is not associated in a change in the
cardiac output. Finally, the increased
vasoconstriction in the renal circulation, particularly in the afferent vessels
as noted by Assali et al. (1953) accounts, in part at least, for the decrease in urinary output. The decrease
in urinary output is part of the toxemic
process and not necessarily a complication.
In summary, then, the toxemic process can be divided into two phases:
the sodium retention phase, and the
phase of sodium retention plus generalized vasoconstriction (fig. 6). The
sodium retention phase is characterized by an increase in plasma volume
which returns to normal following
therapy. Prompt therapy will frequently prevent the development of the
second phase.
Therapy

The availability of the thiazides has
completely changed the concept of the
treatment of toxemia. Prior to their
development, the primary aim of therapy of toxemia was directed toward
the control of arterial pressure and
albuminuria (manisfestations of generalized vasoconstriction). Reserpine,
hydralazine, and veratrum, therefore,
were used extensively in our clinic, as
well as in others. If the arterial pressure could not be lowered sufficiently,
additional antihypertensive agents were
added.
The primary aim of therapy of toxemia, at present, is prompt control of
sodium retention. The effectiveness of
the thiazides in immediately controlling abnormal sodium retention, and in
returning the plasma volume to normal, has frequently prevented the development of generalized vasoconstriction and thereby practically eliminated
the need of antihypertensive therapy
in these patients. When used alone at
the first sign of excessive weight gain,
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Fig. 5-Pathogenesis of toxemia

the thiazides frequently reverse the
toxemic process. Even more important
is the observation that they can be administered continuously without the
development of drug resistance, thus
preventing the development of vasoconstriction. For practical purposes,
the prevention of vasoconstriction is
equivalent to the preventing of toxemia. In our experience, these diuretic
agents have resulted in more than a
70 % reduction in the number of patients with toxemia during the past
two years.
If signs of vasoconstriction (retinal
arterial spasm and albuminuria or
either of them alone) are already present when the patient first presents herself, she probably should be hospitalized. It should be stressed that the
primary aim of therapy in the hospitalized patient is preparation of the
patient for delivery or Cesarean section. Whereas for the out-patient, sodium diuretics are the only agents
needed, in the hospitalized patient
these drugs serve only as background
agents. Vasodilating agents must now
also be administered.
We have recently had experience
with a nondiuretic benzothiadiazine
analogue whose structural formula is
very similar to chlorothiazide (fig. 7).
When administered by mouth it causes
only a small reduction in arterial pressure, and also causes sodium retention
and hyperglycemia. When administered by vein, however, it is a potent
vasodilating agent. The average effective dosage is 300 mg (1 ampule) given
rapidly, undiluted. To date, 69 patients
with severe pre-eclampsia and 2 with
eclampsia have received diazoxide
with excellent results. The typical ef-
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Fig. 6-Two Main phases of toxemia
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feet of 300 mg of diazoxide can be
seen in figure 8. A 35% average reduction in mean arterial pressure occurred
during the first 2 minutes. During the
next 3 to 5 minutes, the arterial pressure increased gradually, leveling off
at 19% average reduction as compared with the control. No signs of
postural hypotension, cerebral ischemia, or collapse were noted.
The fall in arterial pressure with
diazoxide is consistently associated
with an increase in cardiac output, and
a decrease in total peripheral resistance. From the cardiac and cerebral
hemodynamic standpoint, diazoxide
resembles hydralazine since both
agents cause an increase in cardiac
output, heart rate, and cerebral blood
flow. Actual cerebral blood flow determinations have not been performed
in this laboratory, but the lack of
signs of cerebral ischemia accompanying the reduction in arterial pressure,
and the increase in cardiac output,
strongly indicate that there is at least
maintenance of the cerebral blood
flow, even at the point of the greatest
magnitude of hypotensive action.
Our experience thus far would indicate that diazoxide represented a real
advance in the therapy of acute vasospastic hypertension.

Prevention
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Experience has shown that it is
easier to prevent toxemia than to treat
it. Although the thiazide diuretics seem
to be the ideal agents for the treatment
of the sodium retention phase of toxemia, their greatest asset is that they
can be given continuously without the
problem of drug resistance. I feel,
therefore, that the thiazides should
not only be given at the first sign of
sodium retention, but should be instituted from the tenth week of pregnacy in patients who are candidates for
toxemia, e.g., patients with chronic hypertensive vascular disease, patients
with chronic renal disease, and probably all primagravida patients. The data
on more than 6,000 patients treated
with thiazides has shown that the continued use of these drugs following
the tenth week of pregnancy apparently is not harmful to the fetus.
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Panel on Arteriosclerosis*
WILLIAM DOCK, MODERATOR

Dr. William Dock (professor of
medicine, Downstate Medical Center,
State University of New York): One
of the points I should like to make, is
that smoking acts on the circulation
only by the absorption of nicotine. It
has nothing to do with the smoke. In
other words, to get on the wrong side
of the cook-out fire will not increase
much the risk of coronary disease,
although it might give you bronchial
carcinoma after 50 or 100 years. Nicotine acts much as though the individual who smokes a cigarette or gets a
good chew of tobacco had been given
a good intravenous infusion of epinephrine or norepinephrine. The free
fatty acid goes up, the blood pressure
goes up, and the stroke volume goes
up. The stresses produced on the circulation by nicotine are exactly like
those produced by catecholamines.
While you can change to chewing or
switch to a pipe to get rid of obstructive emphysema, the effects of nicotine
on the coronary vessels will be the
same no matter how you absorb it.
We assume the effects of smoking on
coronary disease are what you'd expect if the patient were getting infusions of epinephrine during the day, at
regular and very frequent intervals.
Caffeine also apparently acts in somewhat the same way. Of course, CocaCola does, too. Any of these things
can accelerate atherosclerosis some. As
the people in Cincinnati have reported
repeatedly, and as the nicotine symposium held in New York at the National Academy of Sciences strongly
emphasized, chewers of tobacco have
much worse vascular disease in the
legs and much more coronary disease,
age corrected, than two-pack-a-day
cigarette smokers. Of course, they get

* Held during the Thirty-sixth annual
McGuire Symposium on Hypertension
and Arteriosclerosis, Medical College of
Virginia, October 7-9, 1964.
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the most nicotine for their money. If
you want nicotine, and they want nicotine, there is a price to pay when you
are on the North American diet. On
the other hand, presumably, a tobacco
smoker in North China runs no additional risk of coronary disease, because he runs no risk to begin with.
Dr. William Hollander (associate
professor of medicine, Boston University School of Medicine): Dr. Dock,
could I perhaps comment on the effect
of catecholamines on the metabolism
of the arterial wall? We have some
observations regarding the effects of
norephinephrine on our incubated arterial tissue, including atherosclerotic
tissue. What we have been finding is
that, as you have indicated, catecholamines stimulate the lipoprotein lipase
activity in atherosclerotic tissue. Consequently, the triglyceride content falls
off very strikingly within a period of
four hours. You can actually measure
a drop in the lipid content in these
arterial walls.
What about Buerger's disease? This
disease can be aggravated by smoking.
I do not know what the in vivo effects
of norepinephrine are in Buerger's.
And anyway, in Boston the pathologists say that there is no difference between Buerger's disease and ordinary
atherosclerotic disease of the legs.
Sir George W . Pickering (regius
professor of medicine, Oxford University): Could I disagree with that? I
have been concerned with people with
vascular disease of the legs ever since
I went to work with Sir Thomas Lewis.
These two diseases are quite different
clinically, whatever they are like histologically. Buerger's disease is a disease
of young men which is practically unknown in females, and it stops like that
if you stop smoking. The influence of
tobacco on Buerger's disease is, I
think, 100% .
Dr. Dock: Early Buerger's arteries
are full of lipid only with the North

American diet of the present time.
When you get syphilis, or when you
get Buerger's disease, you get atherosclerosis on top of it because of our
diet. In the regions where people don't
get highly fatty diets you can see pure
Buerger's, and you can see pure syphilitic aortitis without atheroma.
Well, we don't want any of our patients to get syphilis and we hope they
all will stop smoking. The smoking
influence is so clear-cut in statistical
studies that it is a tragedy that it is
easier for a patient to have blood
drawn every week to see how his prothrombin is doing, and take Coumadin
pills, than it is for him to stop buying
tobacco. Tobacco is an extremely addicting drug, probably as addicting as
morphine. And the physiological damage done by tobacco or nicotine is
certainly much worse than that done
by morphine. If you don't smoke
opium, you don't get obstructive emphysema from it. If you take morphine
in little pills, it makes you feel good
just the way smoking does, but it does
not produce the catecholamine effect,
and there is no evidence that it produces arteriosclerosis or even aggravates it. So, we are hoping to get the
Narcotic Act repealed! Everybody on
the panel but me and Dr. Stamler, I
think, are two-pack-a-day or ninepipe-a-day smokers. You see how hard
it is to stop the addiction. Dr. Pickering and I knew three full professors of
medicine in leading American universities who died of obstructive emphysema. Not one of these men could cut
down his smoking though he knew he
was headed for the boneyard. One of
them used to sneak into his garret and
smoke so his wife could not catch him,
and this was after he had been in the
hospital and in a helium tent. So, we
have agreed on the panel that you cannot give up smoking, and most of us
agree, I think, that patients cannot be
persuaded to stay on diets. Dr. Stam-
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ler, can they be persuaded?
Dr. Jeremiah Stamler (director of
the heart disease control program,
City of Chicago Board of Health): The
question is not whether people can be
persuaded to stay on a diet. I think the
question is whether a population can
change its eating habits sufficiently to
alter the pattern of a disease. If what
we are really talking about is meaningful and important, it has a whole lot of
sociological consequences which come
into play beginning with the earliest
period of habit formation, in the time
of weaning. I was talking with Dr.
William Harlan about what happens to
young men in America. They are very
active in athletics, they develop the
training table or the basic training pattern of eating. Then they stop physical
activity when they cease to be active in
athletics or leave the armed forces, but
they keep on eating the same way. Or,
even worse, they fall into the hands of
a wonderful, lovely little girl who
wants to show that she learned the
right things from Mamma about cooking.
Dr. Dock: Now, Dr. Pickering, I
think we should give you a chance to
get back into the argument. In the first
place, does your group feel that diet
has any importance whatever in the
pathogenesis of vascular disease?
Prof. Pickering: As August Krogh
once remarked, "Physiological phenomena are so complicated that, if you
argue from more than one step to
another without the control of experiment, you are almost certain to go
wrong." Before I would be prepared
to encourage a mass change of diet, I
would like to have a pilot study to see
that this mass change was doing a certain amount of good. If I remember
rightly, there is a certain well-known
professor of medicine who put himself
on a very rigid low-fat, no cholesterol
diet, and has since had a cholesterol
stone removed from his gall bladder.
Dr. Dock: And you conclude that it
formed after he went on the diet?
Prof. Pickering: Well, he may have
had it before, that is perfectly true.
Dr. Dock: I think that Dr. Pickering
has brought up a very important point.
A man with asymptomatic gall stones
who goes on a diet with vegetable oil
is very likely to have his stones decrease in size to where they can slip

into the cystic or common duct. Then
he will have his first attack of colic
one, two, or three years after he has
cut his cholesterol intake, because the
stones will get smaller and give symptoms. I have had three such patients.
One of them had his gall stones taken
out at Peter Bent Brigham Hospital
after his fifth attack of colic. His first
attack came on about three years after
he changed his diet. Fortunately he
had had his gall bladder visualized
eight years before, and beautiful, big
cholesterol stones had been seen, far
too big to get into his duct.
I think that if you try to starve too
fast, you may run your serum triglycerides up quite high by starvation.
People have their first bout of myocardial infarction just after they have
gone on a marked weight reduction
program. This has been noted over and
over again. There is a great craze now
in parts of the United States for starvation as the way to start a weight reduction program. It can be predicted
that this should up the incidence of
coronary disease in the first three
months after you go on that sort of
program. Whether it will, I don't
know.
I think that physicians who feel, as
Dr. Pickering and his group do, that
the role of diet in vascular disease is
not yet established, should say as much
to their patients. This seems to me to
be perfectly sound, rational management.
On the other hand, Pickering is a
doctor who thinks perhaps Harvey was
right in saying that if animal experiment indicates that the blood circulates, then it may circulate in man. If
you take animal experiment as being
relevant to human physiology and pathology, and you know that dietary
manipulation will produce vascular
disease in chickens, rats, guinea pigs,
rabbits, dogs, hamsters, monkeys, and
pigs, it does become a little awkward
to say, "Well, we don't believe that
animal experiment is relevant to human experience in this particular
field." It is perfectly sound doctrine to
say this, as it was for Dr. Sydenham to
say, "Just because Harvey thought that
blood circulated in a snake or a deer
is no reason to think that blood circulates in man." To me, this is perfectly
sound, rational argument. Sydenham

was the greatest internist of his generation. You can be a great man in
your generation, and it may turn out
that you were right. Or, it may turn
out that you did not take as seriously
as you should have the data that were
available.
Prof. Pickering: Yes, there is a little
difference, though. You will recall that
Krogh said, "If you argue from one set
of data to another without the control
of experiment you are likely to go
wrong." And I believe that there is a
difference between the rabbit and the
human being. The diet that rabbits eat
in experiments is very different from
the diets that they ordinarily eat. And
the lesion which is produced in rabbits
is not quite the same as the lesion
which produces myocardial infarction
in men. And so, I think your reasoning
will not hold up at every point, and
even if it did, man is a different species
from rabbit. I would like to see the
effect of diet demonstrated in man before I am prepared to believe it is effective in controlling vascular disease.
Dr. Dock: Well, this experiment is
under way in the United States at enormous expense at the present time.
Dr. Stamler: Could I just say a word
about this? I didn't get to hear Sir
George, but I have read some of his
writings, and I had the good fortune
to hear the tape of his lecture earlier
in this symposium. I'd like to dismiss
one or two of the arguments which I
don't think are entirely valid, or, if not
dismiss them, at least put them on the
table for rediscussion. The first is the
question of the rabbit as an atypical
species. The second is the matter of
drowning the animals in very high cholesterol, high fat diets. Both of these
were problems in 1948. I do not think
either is much of a problem now for
the following reasons: 1) The disease
has, in fact, been reproduced, with a
lesion remarkably similar to the human lesions, in a wide range of species,
as Dr. Dock said. So the problem that
did confront workers in the 1930's,
that of the ability to reproduce the disease only in the rabbit or guinea pig,
is no longer entirely true. In fact, quite
the opposite is true. We have the dog,
rat, chicken, rabbit, and a variety of
monkeys. The monkey experiments
have been done using diets similar to
the human diet, in fact, feeding human
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foods in periods that correspond to a
life span equivalent to human beings.
These produced moderate elevations
of the serum cholesterol level in the
200's and 300's, peripheral gangrene,
myocardial infarction, and cerebral infarction.
On the question of experiment in
man, I would like to add a word to
that. As practicing doctors, I think
that the profession has a very difficult
problem. Let's face it, these studies in
the population may not come off. If
they do come off, they will take a decade at least to get an answer. And
what does one do in the interim, wait
for the results of the experiment, and
say, "Well, we're not sure." That's OK,
but every physician who makes that
decision has to accept the corollary of
it, and even has to tell his patient of
the corollary. " If you are a high risk,
middle-aged American man, I have
very little to offer you while I'm waiting for the purity of a scientific answer." Because, really, we do not have
much to offer aside from our approach
to these risk factors, of which diet,
blood cholesterol, and weight are three
key ones. If we are prepared to accept
that corollary, and transmit it to our
patients, then I say we can wait for
the big experiment, if it ever gets done.
If not, I think we should intervene in
a safe way.
Prof. Pickering: Well, that is what I
think I said. If the doctor, himself,
does not believe in this, he should tell
his patients he does not believe in it.
If they want to go on the diet, he is
glad to direct them. If he does believe
in it, he has got to practice what is
known as the Golden Rule and say, "If
I had your trouble, this is what I would
do . . .. " I think this is the best any of
us can do. The same thing applies to
the use of anticoagulants. If the patient says, "Well, would you take this
yourself?" I have to tell him that I
hate to have my arms stuck every
week, and for a difference in mortality
of 4% as against 5% a year, roughly,
I don't believe I would take all of this
trouble.
Dr. Stamler and I have rather different views about atherosclerosis, I
think. He would include a lot of lesions that I suspect are not the same.
Dr. Stam/er: I include only lesions
with porridge in them-no lipid, no
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atherosclerosis, as far as I am concerned. Patients who have been starved
have fibrous plaques and calcium, but
no demonstrable lipid when they die.
It is true in man that the lipid can disappear so you see only the scar of the
disease. If I had to limit the diagnosis
of syphilitic aortitis to people in whom
I could demonstrate treponemes, I
would be out of luck, because penicillin has killed the treponemes in all
of my patients. Just as I diagnose
former syphilitic aortitis from sections,
I now diagnose former atherosclerosis
at autopsy in patients who, as a result
of leukemia, say, have lost a great deal
of weight and been markedly undernourished through periods of about
two years before they died. So you can
lose the lipid from plaques, I'm sure.
Furthermore, I believe that lipid is
present in the lesions of adolescence in
larger quantities than it is in the lesions
of men of 40, and is present in larger
quantities in men who die at 40 than
it is in men who die at 70. These are
my own views. This is almost a question of religious experience. Dr. Pickering belongs to one church, and has
had one religious background in this
field . I belong to a different church,
having had different clergymen working on me in my youth. So, I don't expect to convince Professor Pickering
that the lesions I showed in small vessels are related to the lesions that the
same patients had in their coronary arteries, although both of those patients
from whom I showed you sections
were hypertensives with hypercholesterolemia who died of myocardial infarction. They had lesions in small arteries. Dr. Pickering thinks these are
unrelated to the lesions in the coronaries. I cannot see why they might
not be the same lesions.
Prof. Pickering: Well, I think they
are different. Partially because they
look different, and partially because, in
the small arteries, kidney, and in the
retinal arterioles, lesions are much
more closely correlated with the
height of the arterial pressure than is
the disease I was talking about which
produces big nodules in arteries like
the carotid, and ultimately leads to
thrombosis of them.
I will not agree with Dr. Dock that,
because you can see lipid in them both,
they represent the same disease. He
says we belong to different churches. I
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think he does belong to a church. I am
just a plain agnostic.
Dr. William R. Harlan, Jr. (director of clinical research center, Medical College of Virginia): It is much
easier to make long studies of large
series of cases with a drug than it is
with a diet, and I think this may turn
out in the end to be a more profitable
way of shedding light on what the
plasma lipid has to do with arteriosclerosis in man. It will not settle
whether plasma lipid acts by accelerating coagulation, but at least it would
cast some light on whether changing
the lipid levels in the plasma would
improve the prognosis.
We ought to ask Dr. Stamler about
estrogens and the drug androsterone,
which we produce in our bodies-a
very weak androgen but it tends to
lower blood cholesterol. These two
agents can be given to lower plasma
lipid, at least plasma cholesterol levels,
in male patients. Are you still carrying
on estrogen studies?
Dr. Stam/er: In brief, there are three
reports of a controlled nature on the
estrogens in post-myocardial infarction in man. One of them is a British
study by Oliver and Boyd that deals
with 100 patjents up to age 65. Another is an American study that deals
with men of all ages on lower doses
of mixed conjugated equine estrogen.
Oliver and Boyd used ethanyl estradiol.
The third study is by our group in Chicago, using mixed conjugated equine
estrogens in men under 50. In the 100
patients whom they studied, Oliver and
Boyd got completely negative results,
although serum cholesterol levels were
lower. The Los Angeles study with
lower doses of mixed conjugated
equine estrogen is still in progress, but
there are positive results, particularly
in the patients under 50. I think none
of these studies to date permits a cleancut decision on the efficacy of estrogens. I might note that there is a peculiar aspect to the estrogen work;
while ethanyl estradiol consistently
lowers total blood cholesterol level,
mixed conjugated equine estrogens do
not. They shift the lipoprotein pattern,
but they do not consistently lower the
total cholesterol level. They raise the
a - and may lower the /3- proportionately, so that total cholesterol
changes very little. They do, unques-

tionably, convert the a- from a male
level of about 50 or so to a female
level of 250, 300, 350, or greater.
Whether this is efficacious is, of course,
moot.
Dr. Dock: One of the questions is
whether a reduction in blood pressure
will help us have a lower incidence of
cardiovascular disease. I think you believe it will.
Prof. Pickering: No, I don't believe
it will. I think the evidence suggesting
this is bad.
Dr. Dock: You said that in severe
hypertensives, lowering blood pressure
changes the whole course of the disease. If this is true, how can it help
but lower the death rate?
Prof. Pickering: Oh, I thought you
were talking about arteriosclerosis.
Dr. Dock: No, no. In any sort of
vascular disease, will lowering the
blood pressure improve the prognosis?
Prof. Pickering: Well, it depends on
how high the blood pressure is. If the
blood pressure is very high, or if you
get a patient in the malignant phase
before the kidneys are really very severely involved, then I think the evidence is quite clear that you can prolong the expectation of life.
Dr. Dock: But in a patient with a
lower level of blood pressure and with
a myocardial infarct, is it worthwhile
to try to lower the blood pressure?
Prof. Pickering: No, I would not say
that. But I think that I have distinguished what I would regard as established, and what I would regard as a
sufficient degree of probability, so that
I would use it in the treatment of my
patients. I do not regard it as established that diet will reduce the prevalence of myocardial infarction, but instead, I do advise my patients: 1) to
try to regain their youthful figures, 2)
to substitute corn oil for their ordinary
cooking fat, 3) to take as much exercise as they conveniently can, 4) if
their arterial pressure is high, I reduce
it, and 5) if they are under 55 and
male, I put them on anticoagulants,
but I do not ever go very high with
them, because I am afraid of them. I
do not use anticoagulants in patients
with peptic ulcer, gross hypertension,
or liver disease.
Dr. Dock: Well, I think with this
useful advice, perhaps we had better
bring the meeting to a close.
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Rheumatic Fever: Natural History and
Treatment*
ALVAN R. FEINSTEIN
Yale University School of Medicine, New Haven, Connecticut

Major advances in clinical and laboratory research methods have significantly clarified the identification and
natural course of rheumatic fever in
the past two decades. The advances in
methodology include the following:
Dia gnostic Purity of Population

The label of rheumatic fever is now
given to a population of patients more
distinct and diagnostically "pure" than
ever before. The Jones criteria, described in 1944 and modified in 1956
(American Heart Association, 1956),
circumscribe the diagnostic boundaries
of the disease, and exclude many minor
illnesses that formerly were designated
inappropriately as rheumatic fever.
Other major illnesses that once successfully masqueraded as rheumatic
fever, because they fulfilled the Jones
criteria, can now be unmasked and
properly identified by specific laboratory tests (such as those used for lupus
erythematosus, rheumatoid arthritis,
and sickle cell anemia) and by cardiac
catheterization (for congenital heart
disease). These diagnostic purifications
improve the homogeneity and reproducibility of a population of patients
with rheumatic fever, thus improving
the reliability of conclusions drawn
from observations of the population.
Spectrum of Post-strep tococcal In flammation

The frequent sequential testing of
multiple streptococcal antibodies (a

* Presented at the Richmond Area
Heart Association Symposium on Cardiovascular Diseases, February 10, 1965, at
the Medical College of Virginia. A few
weeks earlier, Dr. Feinstein gave this report before the Second National Conference on Heart Disease in Washington,
D. C.
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laboratory technique developed mainly
in the past two decades) has demonstrated not only that acute rheumatic
fever is constantly associated with
Group A streptococcal infection, but
also that rheumatic fever is merely an
arbitrarily defined collection of events
in the complex clinical spectrum of inflammation which can follow streptococcal infection. Within this spectrum,
the main events used to identify rheumatic fever are arthritis, chorea, or
carditis-occurring alone, in various
combinations, or concomitantly with
other clinical features . Because so
many different combinations of events
can receive a diagnosis of rheumatic
fever, the clinical manifestations of the
disease demonstrate many apparently
disparate patterns. The differences in
these clinical patterns (Massell, Fyler,
and Roy, 1958; Feinstein and Spagnuolo, 1962) were responsible for
much of the past confusion in assessing etiology, pathogenesis, and prognosis. Some of the unclear issues recently resolved are noted below:

failure . When carditis occurs alone
without symptoms created by arthritis,
chorea, fever, or cardiac complications, the carditis will not be examined
while it is acute because the patient
will not seek medical attention; carditis can thus produce its valvular
scars silently. When the scars are discovered many years later, rheumatic
heart disease is said to have occurred
without a "history of rheumatic
fever." This type of rheumatic heart
disease is undetected clinically and develops insidiously only because the
patient is not examined during the
acute phase of the carditis. Had the
patient been symptomatic enough to
seek medical attention, the signs of
carditis could have been found. The
failure of clinicians to find such patients early is thus a fault neither
of clinicians nor patients; it is attributable to the natural behavior of the
disease. When post-streptococcal inflammation produces acute carditis
asymptomatically, it is clinically unexamined and hence undetected.

Isolated Chorea

Severity of Symptoms and Promptness
of Therapy

The latent interval after a streptococcal infection is usually much longer
for Sydenham's chorea than for other
"rheumatic" manifestations. Chorea
may therefore often appear as, or
after, other types of clinical rheumatic
inflammation subside. Or it may occur
alone, i.e., as "pure" chorea, long after
the streptococcal antibody titers have
receded to a level too low to permit
detection of the antecedent infection.

Asymptomatic Carditis
Carditis, another type of inflammation that can occur in the post-streptococcal spectrum, is ordinarily
asymptomatic if unaccompanied by
significant fever or by congestive heart

Although pathologists, from examination of tissue, have long known that
rheumatic fever "licks at the joints
and bites at the heart," the clinical
validity of this maxim, and of its converse has only recently been demonstrated (Feinstein and Spagnuolo,
1962). The patterns of clinical behavior in rheumatic fever show that
patients with severe arthritis are quite
commonly free of carditis, and those
with carditis severe enough to produce
congestive heart failure often have no
joint symptoms. This inverse relationship between the clinical severity of
arthritis and carditis is a feature of
natural history that creates a thera-
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peutic paradox in the disease. The
main reason that residual rheumatic
heart disease occurs less often in patients treated soon after onset of
symptoms than it does in those treated
late is that most patients who seek
treatment early usually do so because
of arthritis. They have little or no carditis to begin with. Conversely, the
late-treatment group consists predominantly of patients whose solitary carditis took a long time to produce
symptoms severe enough to make the
patients seek medical aid. In such patients, the cardiac damage when first
found is usually too great for cure by
anti-inflammatory therapy (Feinstein,
Stern, and Spagnuolo, 1964b). The
natural behavior of the illness, rather
than the treatment, is thus responsible
for many of the successes in which no
heart disease is found after early therapy.
Clinical Identification of Carditis

The assessment of the noises and
shadows used as evidence of carditis
has markedly improved in the past two
decades by recognition and removal of
several older diagnostic impediments:

Reliability of the Examiner
The reliability of the clinical examiner who observes and appraises the
audio-visual evidence of cardiac status
has been greatly improved by use of
objective, "blind," examining techniques, multiple examiners, precise descriptions, and rigorous criteria for interpretation. These improvements in
the scientific performance of the clinician have been aided, and sometimes
evoked, by modern methods of roentgenography and phonocardiography.
As a result of these clinical and technical improvements, better methods
and criteria (Feinstein et al., 1964a
and c) have evolved for avoiding two
types of observational error (described
in the next section) that formerly
created confusion in identifying the
status of patients, evaluating the results of therapy, and understanding the
pathogenesis of rheumatic valvular
disease.

Observational Errors and their Consequences
Errors can be expected during clini-

cal examination of the heart. Errors
of commission, in which physiologic
phenomena are mistakenly regarded
as pathologic, often arise in making
the diagnostic distinctions between:
physiologic systolic murmurs loudly
audible at the apex and those of mitral
regurgitation; long physiologic third
heart sounds and diastolic murmurs;
split first sounds and presystolic murmurs; artifactual curvature of the barium esophagram and left atrial enlargement; physiologic variations in
the roentgenographic cardiac silhouette and those due to cardiomegaly.
As a result of such errors of commission made during an acute rheumatic
attack, "carditis" initially would be diagnosed falsely and its "cure"-when
the true physiologic state was eventually recognized-would later be attributed inappropriately to therapy. At a
subsequent examination of a patient
previously (and correctly) deemed free
of carditis during the acute attack,
such errors would lead to the spurious
belief that rheumatic heart disease had
developed insidiously.
An error of omission occurs when
a pathologic phenomenon is undetected, or mistakenly regarded as
physiologic. Such errors commonly
arise from failure to recognize an
aortic diastolic or apical presystolic
murmur when it is present, particularly in situations where suspicion of
the murmur is not aroused by concomitant hemodynamic or roentgenographic abnormalities. If the abnormal
murmur persisted and eventually were
identified correctly, rheumatic heart
disease would be said to have developed insidiously in a patient believed
to be free of it.
The improved modern auscultatory
procedures described earlier have reduced the incidence of both types of
error, and accordingly, have reduced
the number of patients considered to
have developed rheumatic heart disease insidiously. Recent data (Feinstein et al., 1964a, b, and c; American
Heart Association, 1960) have shown
that insidious rheumatic heart disease
develops de novo primarily in patients
who were asymptomatic and unexamined while they had acute carditis,
and not in those examined during arthritis or chorea and found free of
valvular involvement.

Clarification of Ancillary Tests for
Carditis
Holding the belief that many noncarditic patients might later develop
insidious rheumatic heart disease,
clinicians had avidly searched for
diagnostic aids to find evidence of the
carditis that appeared to be clinically
undetectable. Chief among these aids
were the electrocardiogram and several laboratory tests. Although the
original search for these indices of undetectable "subclinical" carditis was
based on a premise that was itself not
valid, the lack of validity in the existing ECG and laboratory tests for carditis has been demonstrated independently. Prolongation of the P-R interval,
once regarded as a manifestation of
carditis, occurs in about one-third of
patients with post-streptococcal inflammation, regardless of concomitant
clinical evidence of acute carditis.
Moreover, in careful long-term studies (Feinstein et al., 1964a, b, and c;
American Heart Association, 1960),
acute P-R prolongation has been
shown to have no prognostic significance. Alteration of the QT, interval,
an observation whose value was never
proved initially, has now been abandoned as an index of acute rheumatic
carditis. Changes in electrocardiographic T waves of young patientsparticularly in III, in aVF, and in the
transitional precordial V leads-were
once regarded as evidence of carditis,
but are now interpreted with skepticism. Because of normal variations in
the anatomic position of the heart
during respiration and with different
phases of the cardiac cycle, and because of inconsistent placement of the
external probing electrode, T-waves
can vary greatly from one to another
of the repeated ECG's taken in children and adolescents during a rheumatic episode. Of the various laboratory tests popularized in the past 10
years, none-despite a transient, later
discredited, enthusiasm for transaminase-has convincingly been demonstrated to be a specific, reliable index
of carditis. Consequently, cardiac
noises and roentgenographic shadows
remain the major variables that indicate carditis clinically, and the physician remains the major apparatus for
assessing these variables.
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Clinical Course of Acute Rheumatic
Fever

For reasons already cited, no single
clinical pattern can . be properly representative of all the ways in which
rheumatic fever can appear and
evolve. The patterns are composed,
however, of individual clinical manifestations that often do have typical
courses. Untreated rheumatic arthritis
generally lasts no more than several
weeks, sometimes no more than a few
days, and leaves no residual defects.
The knees and ankles are affected most
commonly; elbows, wrists, and hips
are involved less often. Although small
joints of the hands and feet, and the
vertebral or temporo-mandibular joints
may be affected uncommonly in rheumatic fever, an alternate arthropathic
condition should always be considered
and ruled out when these joints are
involved. The arthritis of rheumatic
fever often can involve only one joint,
or several joints simultaneously. The
development of migratory and polyarticular arthritis, polyarticular arthritis alone, often depends upon the
severity of the attack, and the promptness with which bed rest or anti-inflammatory treatment is begun.
Like arthritis, Sydenham's chorea
also leaves no permanent defects, although the young patient may develop
many psychologic scars from scholastic deprivation and from anxieties that
the peculiar movements of the chorea
may induce in him or in the people
who deal with him. The duration and
severity of chorea vary unpredictably
in each patient, making an effective
evaluation of therapy difficult. Some
attacks last only a few weeks, while
others last three or four months. The
movements are rarely so severe as to
threaten the patient's safety, and often
they do not impair ambulation; most
commonly the patient is able to walk
but cannot write, dress, or feed himself. Erythema marginatum seldom
lasts more than one or two dayssometimes only a few hours-and, like
chorea, it often occurs late in a rheumatic attack. It can sometimes occur
early, however, but rarely alone. Subcutaneous nodules are seen much less
frequently today than in the past (the
reasons for the change are unknown)
and almost never occur alone without
some other rheumatic manifestation.
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The nodules most commonly are associated with carditis, and often with severe carditis.
If carditis occurs in a particular attack, the evidence is usually present
when the acutely ill patient is first encountered in the hospital (Massell et
al., 1958; Feinstein and Spagnuolo,
1962). After hospitalization, a patient
admitted with significant murmurs
may develop additional new murmurs,
rubs, changes in heart size, or congestive heart failure, but significant murmurs will seldom appear if none were
present during the first two weeks of
observation. In the most common situation, the patient's carditic manifestations are at their worst when he is
hospitalized, and they then persist or
subside during the ensuing acute
course of the illness.
The belief that acute rheumatic
fever was often a "polycyclic" illness
has also been revised in recent years.
If untreated, an episode of rheumatic
fever usually follows a course of
gradually declining inflammation, in
which laboratory abnormalities last
longer than clinical ones, except for
chorea. The sedimentation rate reaches
normal levels in an average of three
months for patients without carditis,
and in four months for those with carditis. Once a rheumatic attack has begun, anti-inflammatory treatment can
suppress some of the manifestations of
the inflammation, but the treatment
does not repair the damage done to
the heart. The attack may be followed
by rebounds that represent an outlet
for the inflammatory stimulus that remained dormant during the preceding
suppression of inflammation (Feinstein
and Spagnuolo, 1961). Post-therapeutic rebounds are one of three mechanisms by which acute rheumatic inflammation can recrudesce. A second
mechanism is a recurrence of acute
rheumatic fever, provoked by a new
streptococcal infection. A third mechanism, still poorly understood, is present in about 5% of patients with rheumatic fever. In these patients, the
acute attack is excessively prolonged
or "chronic," with clinical and laboratory evidence of acute inflammation
present for more than eight months in
the absence of an intervening streptococcal infection. Unlike post-therapeutic rebounds, the exacerbations of
inflammation in these "chronic" at-

tacks show no temporal relationship
to preceding suppressive treatment.
"Chronic" attacks are most likely to
occur in patients with severe cardiac
damage and in those who have had
many previous episodes of rheumatic
fever (Taranta, Spagnuolo, and Feinstein, 1962).
Long Term Sequelae of Rheumatic
Fever

Great improvements have been produced in the past two decades in epidemiologic methods for careful longterm observation of patient populations
having identified attacks of rheumatic
fever. Several recent large-scale studies
(Feinstein et al., 1964a, b, and c;
American Heart Association, 1960)
of rheumatic sequelae have been performed by cooperative efforts of different groups of investigators or by
single institutions, and have shown the
following results:
(a) Patients initially free of clinical
evidence of carditis remain essentially
free of it thereafter. Rheumatic heart
disease remains in about 9% of patients with equivocal initial evidence
of carditis.
(b) In patients with congestive heart
failure or marked cardiomegaly in the
acute attack, evidence of cardiac damage seldom disappears. Patients with
such severe carditis are the usual
source of those who die at an early
age. If they survive the acute rheumatic episode, the patients with severe
acute carditis often die later as a result of the remaining cardiac damage,
and not necessarily because of persistent or recurrent active rheumatic
inflammation.
(c) Significant murmurs later disappear in about 40% of patients who
had murmurs but no cardiomegaly or
decompensation during a rheumatic
attack. The disappearance of murmurs
is most likely to occur in patients with
systolic rather than diastolic murmurs,
with murmurs of one valve rather than
two, and with no previous episodes of
rheumatic fever.
(d) Except for a small percentage of
patients incapacitated by cardiac symptoms, most rheumatic patients have no
clinical impairment of cardiac function during adolescence, even though
signs of major cardiac damage may be
present. Restriction of scholastic or
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physical activities in such asymptomatic patients appears to have no
medical benefits and may create adverse psychosocial reactions (Feinstein et al., 1962).
(e) Recurrences of rheumatic fever
may make cardiac damage worse in
patients who already have it, but do
not generally bring valvular damage
to patients previously free of it. In
patients without previous valvular
damage, a recurrence is often manifested by arthritis, chorea, or occasionally pericarditis, but seldom by
persistent new valvular murmurs.
Treatment of Acute Rheumatic Fever

Although the many studies of therapy of acute rheumatic fever performed in the past decade have helped
clarify the course of the disease, they
have not reached uniform or consistent agreement about the value of
steroid treatment. The main difficulty
has been the absence of reproducibility in the different methods used to
allocate patients initially into comparable sub-groups of the rheumatic
spectrum, and to identify the presence
and disappearance of carditis (Feinstein, 1961). At present, steroids have
not been proved superior to salicylates
in the routine treatment of rheumatic
fever, nor has either of these agents
been proved consistently more effective than no treatment. Patients without carditis usually emerge free of
heart disease, and those with severe
carditis usually have residual heart
disease, regardless of the mode of
treatment. The comparison of therapeutic agents is thus best restricted to
patients with "mild" carditis, i.e., murmurs only. In such patients, current
therapeutic results are inconclusive
because of lack of uniformity in the
identification of murmurs by different
investigators.
Despite the many therapeutic controversies, certain approaches are accepted almost unanimously:
(a) A course of antimicrobial agents
adequate to eradicate streptococci
should be given when the diagnosis of
acute rheumatic fever is established,
even though throat culture and ASO
titer are normal. Massive doses of antibiotics for long periods of time have
not been proved more effective for
therapy of rheumatic fever than an

ordinary streptococcal-eradicating regimen.
(b) Patients without clinical evidence of carditis can be made comfortable by salicylates or analgesics,
and do not require steroids.
(c) Chorea is a yet unsolved therapeutic enigma, with no consistent success obtained by any of the various
sedatives, tranquillizers, and anti-inflammatory agents that have been
tested.
(d) Steroids are unequivocally better
than salicylates in a small percentage
of rheumatic patients who have overwhelming decompensated carditis, and
whose inflammation can not be controlled with salicylates. In these situations, the steroids do not seem to repair any of the damage left by the
rheumatic fire, but save the heart from
immediate acute destruction by the
fire, even though the severe residual
damage may lead to death a few years
later.
(e) In ordinary mild carditis, steroids have no unequivocally demonstrable superiority to salicylates. The
main advantage of steroids is a more
rapid clinical and laboratory disappearance of certain non-cardiac inflammatory abnormalities; the main
disadvantage of steroids is the frequent development of cutaneous striae
(in young patients) during treatment
and the common occurrence of rebounds after treatment. The rebound
phenomenon after steroids can often
be eliminated or minimized by giving
salicylates as overlap treatment, starting on the date of reduction in steroid
dosage and continuing for at least
several weeks after steroids are
stopped.
These clarifications in our knowledge of natural history of rheumatic
fever have come from better understanding of properties of the streptococcus and of the clinical reactions it
elicits in its human host. The next two
decades of research should help to
clarify the reasons and mechanisms
for susceptibility of the host.
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Radiologic Diagnosis of Congenital
Heart Disease in Children*
RICHARD G. LESTERt

Department of Radiology, Medical College of Virginia, Richmond

Fifteen years ago, a diagnosis of
"congenital heart disease" might have
been considered adequate. Today, all
pediatricians, radiologists, surgeons,
and other physicians would insist on
more precise anatomic and physiologic
information.
The reason for this striking change
is shown in table 1. All the lesions
listed can be corrected by surgery.
They are, then, potentially curable
diseases. Almost all of the common
congenital heart diseases are in this
group. In addition, there are many
active programs in clinical research
centers searching for satisfactory correction of still other lesions, such as
complete transposition of the great vessels (the second most common cyanotic
heart disease), Ebstein's anomaly, and
single ventricle. Even among those conditions that cannot be cured or corrected, ameliorative procedures are
now available. The Blalock operation
for tetralogy of Fallot is such a procedure. In this operation, the subclavian
artery is used as a shunt vessel to carry
blood from the systemic circuit into the
pulmonary arterial tree. Another is the
Glenn procedure, a superior vena
cava-pulmonary artery anastomosis.
Anomalies of the cardiovascular system are a common cause of disease in
children. Approximately six of every
one thousand live births have some
form of congenital heart disease. The
prognosis of many of these conditions
is very poor. About 90% of infants born
with complete transposition of the
great vessels succumb within the first
year of life. Consequently, early and
accurate diagnosis is essential.

* Presented at the Richmqnd Area
Heart Association Symposium on Cardiovascular Diseases, February 10, 1965, at
the Medical College of Virginia. ·
t Dr. Lester is now professor and
chairman, department of radiology, Duke
University.
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Classification of Congenital Heart
Disease

Classifications based on either anatomic or physiologic pathology are
helpful in this regard, and many have
been proposed. Because most of the
observable clinical abnormalities are
reflections of pathologic physiology,
the latter approach is more useful.

The simplest classification of this
sort is based on the presence or absence of visible cyanosis (table 2A).
Patients with desaturated hemoglobin
in the peripheral arterial circulation
(that is, with right-to-left shunt of
blood), as in tetralogy of Fallot or
complete transposition of the great
vessels, are separated from those with

TABLE 1

Some Cardiac Lesions that can be Corrected

Ventricular septa! defect
Atrial septa! defect
Atrioventricularis communis
Patent ductus arteriosus
Aortico-pulmonary window
Coronary artery fistula
Ruptured sinus of Valsalva
Coarctation of the aorta
Aortic stenosis
Supravalvular aortic stenosis

Subvalvular aortic stenosis
Tetralogy of Fallot
The grand trilogy
Total anomalous pulmonary venous connection
Partial anomalous pulmonary venous connection
Pulmonary valvular stenosis
Aortic ring
Cardiac tumors
Congenital ventricular aneurysm
Congenital mitral stenosis

TABLE 2

Classifications of Congenital Cardiac Lesions
A

B

Clinical Classification

Roentgenologic Classification

Acyanotic

Left to right shunts
Stenotic lesions: right sided
left sided
Myocardial lesions
Some pulmonary venous obstructive
lesions
Cyanotic

Pulmonary obstruction with right to
left shunt
Admixture lesions
Some pulmonary venous obstructive
lesions

Increased pulmonary arterial vasculature

Left to right shunts
Admixture lesions
Normal pulmonary arterial vasculature

Stenotic lesions : left sided
right sided
Myocardial lesions
Decreased pulmonary arterial vasculature

Pulmonary obstruction with right to
left shunt
Increased pulmonary venous vasculature

Pulmonary venous obstructive lesions
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a left-to-right shunt (such as ventricular septal defect) or those with cardiac
conditions without shunt (e.g., coarctation of the aorta).
This classification has inherent disadvantages, however. Many infants
and children with conditions characterized by right-to-left shunts have
an insufficient quantity of desaturated
hemoglobin in the peripheral circulation to be observably blue. About 5
g% of desaturated hemoglobin is required for visible cyanosis, and this
is dependent upon a number of factors,
such as skin pigmentation. In addition,
cyanosis may result from extensive
pneumonia, and other pulmonary conditions. For these reasons, a classification (table 2B), based on radiologic
observation of the pulmonary blood
vessels, was proposed a number of
years ago (Lester, Gedgaudas, and
Rigler, 1958). This method, too, is
based on physiologic considerations.
Congenital cardiac conditions are separated into groups dependent upon
the pulmonary vascular blood flow.
Decreased Pulmonary Arterial Vasculature

Patients with a decrease in pulmonary arterial vasculature must have
both an obstruction of pulmonary
flow (such as pulmonary stenosis or
right ventricular infundibular obstruction) and a right-to-left shunt of blood
(e.g., through a ventricular septal defect). Tetralogy of Fallot is an example
of this, and is defined as infundibular
stenosis with ventricular septal defect and right-to-left shunt. Other
lesions falling into this group are
shown in table 3. Patients with these
lesions show arterial 0 2 desaturation
and may be visibly cyanotic. Differential diagnoses within this or other
groups may be accomplished by
further roentgen observations.
Increased Pulmonary Arterial
Vasculature

Patients showing an increase in pulmonary arterial vasculature fall into
one of two sub-groups. By far, the
more common is the left-to-right shunt
series. These include intracardiac leftto-right shunts, such as ventricular
septal defect, and atrial septal defect.

TABLE 3

TABLE 4

Decreased
Pulmonary
Arterial
Vasculature (Cyanotic)

Increased
Pulmonary
Arterial
Vasculature (Acyanotic)

Tetralogy of Fallot
The grand trilogy
Pulmonary atresia
" Pseudotruncus arteriosus"
Tricuspid atresia
Ebstein's anomaly (with right to
left atrial shunt)
Primary pulmonary hypertension
with patent foramen ovale
Pulmonary arterial hypoplasia or
coarctation (may be unilateral)
Origin of both great vessels from
right ventricle with pulmonary
stenosis
Complete transposition of the great
vessels with pulmonary stenosis
or atresia
Truncus arteriosus, type IV

Left to Right Shunts
Ventricular septa! defect
A trial septa! defect
A trioventricularis communis
Left ventricular-right atrial communication
Patent ductus arteriosus
Aortico-pulmonary window
Ruptured sinus of Valsalva
Coronary artery fistula to right
atrium, right ventricle or pulmonary artery
Partial anomalous pulmonary venous connection
Lutembacher's syndrome
Corrected transposition with left to
right shunt

Such patients are, of course, fully
saturated. In this series, increased pulmonary vasculature is associated with
an enlarged, undivided pulmonary artery, and with an aorta that appears
normal or somewhat small, and is
relatively hypopulsatile. Extracardiac
left-to-right shunts include patent ductus arteriosus and aortico-pulmonary
window. In these patients, the aorta
appears hyperpulsatile and may be
enlarged. In addition, extracardiac to
intracardiac left-to-right shunts may
be seen, such as aneurysm of a sinus of
Valsalva with fistula formation and
coronary artery fistula (table 4).
In addition, patients with admixture
lesions, where both a left-to-right
shunt and a right-to-left shunt are essential for maintaining life, usually
show increased pulmonary arterial vasculature. In truncus arteriosus, for
example, the blood flow from both
the left and right ventricles enters a
common trunk, from which the flow
into the systemic and the pulmonary
circulations arises. In complete transposition of the great vessels, too, there
is invariably shunting in both directions. These patients are, of course, desaturated, and may be visibly blue. In
the admixture group there is frequently
(although not always) some degree of
malposition of the great vessels. As a
result, although the pulmonary arterial
vasculature is increased on the roent-

TABLE 5

Increased
Pulmonary
Arterial
Vasculature (Cyanotic)

Admixture Lesions
Complete transposition of the great
vessels
Origin of both great vessels from
right ventricle without pulmonary stenosis
Other forms of partial transposition of the great vessels
Truncus arteriosus , types I, II, III
Single ventricle
Cor biloculare
Total anomalous pulmonary venous connection
Tricuspid atresia with transposition
of the great vessels
Shunt with High Pulmonary Resistance

"Eisenmenger complex" and "Eisen menger physiology"
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genograms, the area of the undivided
pulmonary artery may appear flat or
concave. This is not because the pulmonary artery is small, but rather because
it is malpositioned (table 5).
Normal Pulmonary Vasculature

When the pulmonary arterial vasculature is normal, the lesion is of a
variety not associated with shunt
mechanisms. Of course, a shunt defect
not physiologically significant will also
show no abnormality of pulmonary
vasculature. These lesions too can be
sub-grouped into left-sided ones (coarctation of the aorta), right-sided
(isolated pulmonary valvular stenosis),
and more generalized ones (Von Gierke's Disease) (table 6).
Pulmonary Venous Obstruction

In addition, there is a series of relatively rare but important diseases,
characterized by pulmonary venous
obstruction. These lesions can be recognized by a reticular pattern in the
lung fields that represents, not engorged
pulmonary arterial vessels, but engorged venous vessels and lymphatics.
These patients also may show repeated
bouts of pulmonary edema. Such conditions as cor triatriatum and total
anomalous pulmonary venous connection to the portal venous system fall
into this group (table 7). It should be
noted that the more common varieties
of total anomalous pulmonary venous
connection are admixture lesions, not
pulmonary venous obstructive lesions.
Choice of Radiologic Procedure

Although the status of the pulmonary arterial and venous vasculature
is best defined in the frontal roentgenogram, other findings are of particular
help in the differential diagnosis of
conditions within the major groupings.
These include the size and pulsations
of the aorta, the pulsations of the pulmonary arterial vessels themselves, the
size of the left atrium, and the size of
the ventricles. For this reason, the
frontal view chest roentgenogram is
not a satisfactory examination of the
heart. Rather, a series of films and a
brief and appropriate fluoroscopic examination are required for full evaluation.
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TABLE 6

Normal Pulmonary Arterial Vasculature (Acyanotic)

Coarctation of aorta
Aortic stenosis or insufficiency
Aortic ring
Endocardial fibroelastosis
Cor triatriatum
Pulmonary valvular stenosis
Friedreich 's ataxia heart disease
Marfan's disease

Von Gierke 's disease
Hurler's disease and other metabolic heart
disease
Sickle cell disease and other anemias
Congenital ventricular aneurysm
Anomalous origin of a coronary artery
Coronary artery fistula to left side of heart
Complete heart block
Cardiac tumors
Hypertensive heart disease

TABLE 7

Increased

TABLE 8

Pulmonary
Vasculature

Venous

Stenosis or atresia of pulmonary
veins
Cor triatriatum
Mitra! atresia
Mitra) stenosis
Anomalous pulmonary venous connection, through stenotic channels
Anomalous pulmonary venous connection to the portal venous system
Aortic atresia
Severe aortic stenosis
Severe coarctation of the aorta
Complete interruption of the aortic
arch

The routine cardiac films most suitable for differential diagnosis are listed
in table 8.
The status of fluoroscopic examination has been brought into question in
recent years. This is a result of
misunderstanding the use of the fluoroscope in these conditions. It is feckless to use the fluoroscopic examination for evaluating factors which can
be determined better from the roentgenograms. On the other hand, dynamic characteristics, such as the pulsations of the undivided pulmonary
artery and its major branches and the
pulsations of the aorta, can be evaluated only by fluoroscopy. For this
purpose, image intensification fluoroscopy, rather than a conventional fluoroscope, is essential.

Initial Cardiac Films

(All Films at 6 Foot Target-Film
Distance-Upright)
Postero-anterior*
Lateral*
Right anterior oblique, 45 °*
Left anterior oblique, 60 °
* Thick barium in esophagus .
Additional Film s

Supine antero-posterior at 30 inch
distance- for left atrium
Roentgen kymograms- for valve
calcification, pulsations
Cinefluorographic strips-for pulsations , calcifications
Planigrams- for valve calcification

Evaluation of Radiographic and
Fluoroscopic Findings

An order of significance of radiographic and fluoroscopic findings can
be derived . Some features, such as the
status of the pulmonary arterial vasculature, are well evaluated radiographically and are consequently of great
significance. Others, such as chamber
enlargement with the exception of left
atrial enlargement, are poorly evaluated
radiographically and other methods are
more satisfactory. An order of significance is indicated in table 9.
Utilizing simple roentgen methods
(radiographic films and image intensification fluoroscopy) in association with
the other simple diagnostic methods
(physical examination, history, and
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electrocardiography), a firm clinical diagnosis can be established in more than
85% of the patients. However, further
information is usually needed. A decision to attempt surgical correction depends upon precise knowledge of the
physiologic effect of the anatomic defect. For example, a patient with ventricular septa! defect, having only a
modest increase in pulmonary arterial
pressure, represents an excellent surgical risk. Appropriate repair should result in complete correction of the condition. On the other hand, a patient
having very high pulmonary resistance
may be a poor risk, and surgery may
be contra-indicated. This sort of data
is best established by cardiac catheterization.

TABLE 9

TABLE 11

Radiographic
and
Fluoroscopic
Findings in Order of Significance

Some

Pulmonary arterial vasculature
a. Normal, increased or decreased
on radiographs
b. Degree and character of pulsations at fluoroscopy
Pulmonary venous vasculature and
pulmonary lymphatics
Size and pulsations of undivided pulmonary artery
Size and pulsations of aorta
Heart size
Chamber enlargement
a. Left atrium
b. Right ventricle
c. Left ventricle
d. Right atrium

Evaluation of mitral competance in
acquired heart disease
Evaluation of mitral competance following surgery for mitral disease
Subvalvular aortic stenosis
Small intracardiac and extracardiac
left to right shunts with questionable findings at right heart
catheterization ; anatomic definition of such lesions
Balanced septa! defects
Patent ductus arteriosus associated
with pulmonary insufficiency or
with ventricular septa! defect
Certain admixture lesions
Evaluation of left side of heart in
complex congenital anomalies

Selective Angiocardiography

Surgical correction also is dependent
upon a knowledge of the precise anatomic pathology. In tetralogy of Fallot,
for example, the degree of infundibular obstruction, the length of the hypertrophied crista supraventricularis,
the size of the ventricular septal defect, the degree of pulmonary valvular
obstruction, and the degree of overriding of the aorta are all of great
importance. This sort of precise anatomic information requires selective
angiocardiography.
Generally, venous angiocardiography (injection of a bolus of contrast
material into a peripheral vein with
filming of the heart) is unsatisfactory
because of overlapping structures and
a poor concentration of contrast material at the point of interest. Selective
study, with a catheter placed in relation to the expected area of maximum
importance, is much superior and
should replace the cruder methods. In
order to accomplish this, the conventional studies must be used in order to
determine what information is to be
obtained. Right-sided selective angiocardiography is most satisfactory in a
large variety of conditions. These include tetralogy of Fallot and pulmonary stenosis (table 10). Injection into
the left side of the heart is required
in others (table 11). In extracardiac
conditions involving the aorta, selective injection above the aortic valve,
or other locations within the aorta,
may be necessary (table 12).

Indications for Left Sided
Ang ioca rd iog ra phy

TABLE 10

Some Indications for Right Sided
Angiocardiography

Congenital heart disease with decreased pulmonary arterial vasculature
Congenital heart disease with increased pulmonary arterial vasculature
a. Admixture lesions
b. Bidirectional shunt
Anatomic definition of pulmonary
valvular and/ or infundibular
stenosis
Anomalies of the pulmonary vascular tree
Inability to enter the pulmonary artery at cardiac catheterization
Congenital heart disease with increased pulmonary venous vasculature
Differential diagnosis between cardiac dilatation and pericardia!
effusion
Cardiac tumors
Certain pericardiac tumors

TABLE 12

Some

Indications for
Aortography

Thoracic

Coarctation of the aorta
Patent ductus arteriosus
Aortico-pulmonary window
Coronary artery fistula
Anomalous coronary artery
Ruptured 'sinus of Valsalva
Aortic stenosis and/ or insufficiency
Supravalvular aortic stenosis
Aortic ring
Aneurysm of the aorta
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Summary

1. The importance of precise anatomic and physiologic diagnosis in
congenital heart disease has been emphasized in recent years, because of
the increasing possibilities of surgical
correction.
2. The x-ray examination is a
powerful tool in the evaluation of patients with congenital heart disease. A
method of evaluation is presented, using conventional roentgenographic and
fluoroscopic examination along with
other simple clinical methods. This
approach is relatively simple, can be
carried out as an office procedure, and
yields a firm clinical diagnosis in the
majority of cases.
3. Cardiac catheterization and selective angiocardiography may be necessary to give precise information on
physiological abnormalities and anatomic defects. These techniques require expensive equipment and a team
of physicians.
4. The challenge of accurate diagnosis in these common anomalies is
great. The potential reward, in terms
of restoring a normal life span, is also
great. An aggressive approach to a
correct diagnosis is urged.
Reference
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Renogram) was born in 1935
in Washington, D. C. He obtained both his M. D. and
Ph. D. degrees from the Medical College of Virginia. An
NIH fellowship permitted
him to spend four years working with Dr. Sidney Solomon
in the department of physiology at the Medical College
of Virginia. He is now assistant professor in the department of biometry at
Emory University, Atlanta,
Ga.
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A. John Honour (Central
Nervous Control of Blood
Pressure in Man) is Research
Officer and Administrator in
the department of Sir G. W.
Pickering, the Regius Professor of Medicine in the
University of Oxford, where
he received his M.A. and
D.Phil. degrees. He also spent
several years with the Medical Research Council of Great
Britain in the laboratories of
the late Sir Thomas Lewis at
University College Hospital
Medical School, and then
worked in the department of
physiology, University of
British Columbia, Vancouver,
Canada.

Hermes A. Kontos (Physiological Basis of the Radioisotope Renogram) is instructor in medicine at the Medical
College of Virginia. He was
born in Cyprus and received
a medical degree from the
University of Athens, Greece,
in 1958. He took his residency training in medicine at
the Medical College of Virginia.

Joseph H. Magee (Physiological Basis of the Radioisotope Renogram) is a graduate
of the University of Virginia
Medical School. He interned
at the Johns Hopkins Hospital, and was a resident at the
Philadelphia General Hospital and the V. A. Hospital,
Washington, D. C. He joined
the Medical College of Virginia staff in 1957 as associate
in medicine, and is now assistant professor at Jefferson
Medical College, Philadelphia, Pa.

James Franklin Oates, ill
(Physiological Basis of the
Radioisotope Renogram) is a
clinical instructor in surgery
at the Medical College of
Virginia and a member of the
teaching staff at the Richmond Memorial Hospital. He
received a B. A. degree from
Princeton University and an
M. D. degree from Cornell.
His postgraduate medical
training was done at the
Peter Bent Brigham Hospital,
the Walter Reed Army Institute of Research, the Medical
College of Virginia, and the
V. A. Hospital in Richmond.

Richard G. Lester (Radiologic Diagnosis of Congenital
Heart Disease in Children)
became chairman of the department of radiology at the
Medical College of Virginia
in 1961. Dr. Lester was born
in 1925 in New York City
and educated at Princeton
University and Columbia
University College of Physicians and Surgeons. After
training at New York City
Hospital and Stanford University Hospital, he spent
several years in the department of radiology at the University of Minnesota before
coming to Richmond. In July
of this year he moved to Durham, N. C., to head the department of radiology at
Duke University.
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Sir George White Pickering
(What is a Modern Physician?), Regius professor of
medicine at Oxford University since 1956, was the McGuire Lecturer at the Medical
College of Virginia in 1964.
From 1939 to 1956 he was
professor of medicine at the
University of London, and
director of the medical clinic
of St. Mary's Hospital in
London. Professor Pickering
was educated at Dulwich and
Pembroke Colleges of Cambridge University. He is a
member of the Association of
American Physicians and a
Fellow of the Royal Society;
he served as president of the
British Medical Association
from 1963 to 1964. In the
fall of 1964, he spent one
week at the Medical College
of Virginia as a visiting professor in the department of
medicine.
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David W. Richardson (Central Nervous Control of Blood
Pressure in Man) is associate
professor of medicine and occupant of the Virginia Heart
Association chair of cardiovascular research at the
Medical College of Virginia.
After receiving his M .D . from
H arvard, he interned and
started his medical residency
at Yale. He completed his
clinical and research training
at M.C.V. From 1956 to 1961
he was chief of the cardiovascular section and associate
chief of staff for research at
the Richmond V.A. Hospital.
He has remained in Richmond except for the academic year 1962-1963, which
he spent as a visiting fellow
in the research laboratories of
Sir George Pickering, at the
University of Oxford, England.

Edwin F. Rosinski (An
Approach to Medical Education: The Medical College of
Virginia School of Medicine
Curriculum) is professor of
medical education and director of research in medical
education at M.C.V. He is a
consultant on medical education for the medical and natural sciences division of the
Rockefeller Foundation. Dr.
Rosinski came to M.C.V. in
1959 from the University of
Buffalo School of Medicine
where he had directed research for Project in Medical
Education. He also received
his Ed.D. degree and served
as senior research associate at
that university.

Ralph M. Scott (Place of
Radiotherapy in the Management of Oral Cancer) is professor of radiology and director of rndiation therapy at
the University of Louisville
School of Medicine. Before
moving to Kentucky, he was
in charge of radiation therapy
and nuclear medicine at the
Robert Packer Hospital and
Guthrie Clinic in Sayre, Pa.,
and later assistant professor
of radiology at the University
of Chicago School of Medicine. Dr. Scott was born in
Leemont, Va., received his
B.A. from the University of
Virginia, and his M.D. at the
Medical College of Virginia.
Part of his earlier training in
radiation therapy was during
a fellowship at the Christie
Hospital and Holt Institute in
Manchester, England.

Malcolm E. Turner (Physiological Basis of the Radioisotope Renogram) is professor and chairman of the
department of biometry at
Emory University. Before going there he was chairman of
the division of biometry, department of biophysics, at
the Medical College of Virginia. Dr. Turner received his
Ph.D. degree from North
Carolina State College. He
has held teaching positions at
the University of Cincinnati
College of Medicine and at
North Carolina State College.
He is currently managing editor of Biometrics.

Alton R. Sharpe, Jr. (Physiological Basis of the Radioisotope Renogram) is associate professor of nuclear
medicine at the Medical College of Virginia. He earned
his B.S. degree at the University of Richmond and his
M.D. degree at the Medical
College of Virginia, and later
did his internship and residency at M. C. V. He has
served as chief of the radioisotope laboratory, associate
chief of staff for research, and
consultant in nuclear medicine at the McGuire V. A.
Hospital in Richmond.

Panelists at the McGuire Symposium, 1964. From left , Sir George Pickering, Ors. Harold W. Schnaper (chief, re·
search in Internal Medicine, V.A. Central Office , Washington, D.C.), William Hollander, William Dock, Jeremiah
Stamler, William R . H a rlan , Jr., and Lyman A. Fisher.
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Calender of ~jStgraduate Education

MEDICAL COLLEGE OF VIRGINIA / FALL 1965

TUESDAY-SEPTEMBER 21

A.M.
SEPTEMBER 20-24, 1965
AMERICAN COLLEGE OF PHYSICIANS COURSE
ON BASIC MECHANISMS IN INTERNAL MEDICINE
A five-day course, open to all interested physicians, to be
held in the Porter Auditorium, Medical Education Building, September 20-24, 1965.
MONDAY-SEPTEMBER 20

A.M.
8:00 Registration
8:45 Welcome-Dr. Kinloch Nelson, Dean, School of
Medicine, co-director. Dr. Charles M. Caravati, department of medicine, MCV, and vice-president,
American College of Physicians, co-director. Dr.
W. T. Thompson, Jr., chairman, department of
medicine, MCV, director.
GASTROENTEROLOGY

9:00 Changing Patterns of Pancreatitis-Dr. Benjamin B.
Weisiger, McGuire V. A. Hospital, Richmond, Va.
9:25 Interrelationships between Malabsorption and Maldigestion Syndromes-Dr. John T. Farrar, department of medicine, MCV.
10:15 Intermission
10:25 Cholestatic Jaundice-Dr. Fenton Schaffner, department of pathology, Mount Sinai Hospital, New
York, N. Y.
11:10 Achalasia, Diffuse Esophageal Spasm and Related
Disorders-Dr. Alvin M. Zfass, department of medicine, MCV.
11:30 Panel: "Pearl Diving"-Drs. Caravati, Farrar,
Schaffner, Weisiger, and Zfass.
P.M.
RENAL-SALT AND WATER
1:30 Current Concepts of Renal Physiology; Clinical
Evaluation-Dr. Newton C. Brackett, department of

medicine, MCV.
2:00 Renal Tubular Function; Syndromes of Altered
Function-Dr. T. Franklin Williams, University of
North Carolina School of Medicine.
2:30 Disturbances of Acid-Base Equilibrium-Dr. Brackett.
3:30 Intermission
3:45 Nephrosis; Diagnosis and Management-Dr. Russell
Randall, department of medicine, MCV.
4:15 Acute Renal Failure; Diagnosis and ManagementDr. I. Norman Sporn, department of medicine,
MCV.
4:45 Chronic Renal Failure; Methods of Management;
Renal Transplant-Dr. John Setter, department of
medicine, MCV.
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NEUROLOGY

8:30 Clinical Syndromes and Diagnostic Procedures in
"Stroke"-Dr. Laurie E. Rennie, division of neurology, department of medicine, MCV.
9:15 Use of Echoencephalogram in Neurological Diagnosis-Dr. Mitchell J. Dreese, associate professor,
division of neurology, department of medicine,
MCV.
9:30 Chronic Meningitis; Diagnosis and Treatment (Emphasis on Fungus Infection)
10: 15 Intermission
10:30 Diagnosis of Muscular Weakness-Dr. Cary G .
Suter, chairman, division of neurology, department
of medicine, MCV.
11:15 Muscle Biopsy for Diagnosis of Muscle DiseaseDr. Julio Garcia, department of pathology, MCV.
11:30 Chemical Tests in the Diagnosis of Neurological
Disease-Dr. Nicholas Papadopoulos, Walter Reed
Army Institute of Research, Washington, D. C.
P.M.
HEMATOLOGY

1:30 The Peripheral Blood Smear, Its Value in Diagnosis-Dr. G. Watson James, III, department of
medicine, MCV.
2:00 Critique of Recent Advances in Hematology-Dr.
Oscar 0. Thorup, department of medicine, MCV.
2:45 Uncommon Hemolytic Anemia and Red Cell Enzyme Systems-Dr. John Moon, department of
medicine, MCV.
3:05 Intermission
3:20 Chronic Granulocytic Leukemia, Its Variants and
Clinical Variability-Dr. Waldo Scott, Newport
News, Va.
3:40 Understanding Coagulation Disorders-Dr. Lyman
Fisher, division of clinical pathology, department of
pathology, MCV.
4:10 Differential Diagnosis of Vitamin Bl:!. and Folic
Acid-Deficiency Anemia-Dr. William T . Dabney,
III, department of medicine, MCV.
4:35 The Thymus, Lymphoreticular Disease and y-Globulin Abnormalities-Dr. James.
7:00 Faculty "open offices and laboratories"-Medical
to Education Building; Elective seminars and group
9:00 discussions.
WEDNESDAY-SEPTEMBER 22

A.M.
CARDIOVASCULAR-PULMONARY

8:30 Basic Physiology; Cardiac Catheterization in the
Evaluation of Acquired Valvular Disease-Dr. V.
E. Kemp, department of medicine, MCV.
9: 15 Application of Catheterization to Diagnosis of Common Congenital Heart Disease-Dr. H. Page Mauck,
department of medicine, MCV.

9:45 Intermission
11 :30 Arrhythmias and Cardioversion-Dr. Alston Blount,
Richmond, Va.
P.M.
1:30 Pulmonary Physiology for the Clinician-Dr.
Thompson.
2:00 Considerations and Applications of Hyperbaric
Oxygenation-Dr. Herbert 0. Sieker, department of
medicine, Duke University School of Medicine.
2:45 Intermission
3:00 Panel Discussion on Emphysema; etiology, pathophysiology, and treatment-Moderator, Dr. John L.
Patterson, Jr., department of medicine, MCV. Copanelists, Dr. Edward S. Ray, department of medicine, MCV; Drs. Sieker and Thompson.
4:00 Treatment of Bacterial Pneumonias (Emphasis on
New Agents)-Dr. Utz.
4:30 Asbestosis and Pulmonary Malignancies-Dr. Harry
I. Lurie, department of pathology, MCV.
4:45 Alveolar Proteinosis-Dr. C. F. Wingo, V. A. Hospital, Richmond, Va.
THURSDAY-SEPTEMBER 23
A.M.

CARDIOVASCULAR-PULMONARY, cont.
8:30 Control of Blood Pressure-Dr. Eugene Stead,
chairman, department of medicine, Duke University School of Medicine.
9:15 Efficacy of Drug Treatment of Hypertension-Dr.
·· David W. Richardson, department of medicine,
MCV.
9:30 Panel: Diagnosis of Surgically Curable Hypertension and Efficacy of Therapy-Moderator, Dr.
Richardson. Co-panelists, Dr. Hume, chairman, department of surgery, MCV; Dr. Charles 0. Watlington, department of medicine, and Dr. Stead.
10:00 Intermission
10: 15 (Panel continued)
10:45 Panel: Coronary Disease-Moderator, Dr. Kemp.
Co-panelists: Dr. William H. Sewell, V.A. Hospital,
Oteen, N. C.; Dr. John W. Jones, department of
medicine, McGuire V.A. Hospital.
11 :30 Digitalis-Dr. Eugene Braunwald, chief, Cardiology
Branch, National Heart Institute, National Institute
of Health, Bethesda, Md.
P.M.
CONNECTIVE TISSUE

1:30 Plasma Proteins in Health and Disease-Dr. P.
Franklin Mullinax-department of medicine, MCV.
2:00 Significance of the Serologic Reactions of the Rheumatoid Factors-Dr. Marion Waller, department of
medicine, MCV.
2:30 Synovial Reaction in Rheumatoid Arthritis, Gout,
and Pseudogout-Dr. Daniel J. McCarty, Hahneman Medical Center, Philadelphia, Pa.
3:00 Intermission
3:15 Current Concepts of Pathogenesis and Treatment

3:45

4:15

4:45
7:00
to
9:00

of Gout-Dr. W. Robert Irby, department of medicine, MCV.
Systemic Manifestations of Rheumatoid ArthritisDr. John Kelly, chief, medical service, McGuire
V.A. Hospital.
Problems of Treatment of Rheumatoid ArthritisDr. Elam C. Toone, Jr., department of medicine,
MCV.
Summation
Faculty "open offices and laboratories"-Medical
Education Building; Elective seminars and group
discussions.

FRIDAY-SEPTEMBER 24
A.M.
ENDOCRINOLOGY AND METABOLISM

8:30 Advances in EndocrinologyThe Thyroid-Dr. Richard N. Kirkland, department of medicine, MCV.
The Adrenals-Dr. Herhchel L. Estep, department of medicine, MCV.
The Parathyroids-Dr. John R. Handy, department of medicine, McGuire V.A. Hospital.
9:30 Principles of Lipid Metabolism-Dr. William R.
Harlan, Jr., director, Clinical Research Center, MCV.
10.00 Intermission
10:15 Disorders of Lipid Metabolism-Dr. Harlan.
10:45 What is Diabetes-Dr. H. St. George Tucker, Jr.,
department of medicine, MCV.
11:15 Chromosomal Disorders-Dr. Ruben B. Young, department of pediatrics, MCV.
11:45 Newer Isotope Scanning Procedures-Dr. Alton R.
Sharpe, Jr., department of radiology, MCV.
P.M.
DERMATOLOGY
1:30 Dermal Elastoses; Biochemical and Clinical Manifestations-Dr. J. Doyle Smith, chairman, department of chemistry and pharmaceutical chemistry,
school of pharmacy, MCV.
2:30 Metabolic Abnormalities Refiected in the Skin and
Mucous Membranes-Dr. Robert Scoggins, division
of dermatology, department of medicine, MCV.
3 :00 Intermission
3:15 Cutaneous Manifestations of the Collagen Vascular
Diseases-Dr. Allen Pepple, chairman, division of
dermatology, department of medicine, MCV.
3:45 Dermatologic Clues to Internal Malignancies-Dr.
Kenneth W. Blaylock, division of dermatology, department of medicine, MCV.
4:15 The Sweat Gland in Health and Disease-Dr. Gary
W. Cage, National Cancer Institute, National Institute of Health, Bethesda, Maryland.
TUITION

$60 for members of the College, $100 for non-members.
For further information and registration, contact Dr. Edward C. Rosenow, Jr., executive director, American College
of Physicians, 4200 Pine Street, Philadelphia, Pa.,._ or Dr.
W. T. Thompson, Jr., chairman, department of medicine,
MCV.
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MCV/Q
MEDICAL COLLEGE OF VIRGINIA QUARTERLY

A Scientific Publication of the School of Medicine

The MEDICAL COLLEGE OF VIRGINIA
QUARTERLY is designed primarily for the postgraduate education of physicians. The QUARTERLY
will publish results of original research in basic and
clinical sciences, and report on seminars and symposiums held at the College. Contributions from outside the MCV faculty are invited.
Manuscripts, submitted in duplicate, should be
prepared according to recommendations in the Style
Manual for Biological Journals, 2nd ed., published
in 1964 by the American Institute of Biological Sciences, 2000 P Street, N.W., Washington, D.C. 20036.
Subscription rates in the USA and Canada : 1 year,
$4; 2 years, $8 ; 3 years, $10. House staff, medical
students, and fellows : 1 year, $2.
Correspondence : MEDICAL COLLEGE OF
VIRGINIA QUARTERLY, Medical College of Virginia, Richmond, Va. 23219. Phone : 703-644-9851.
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